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ABSTRACT

IN VITRO EVALUATION OF MECHANICAL HEART VALVE PERFORMANCE USING A
NOVEL TEST CHAMBER IN AN AUTOMATED MOCK CIRCULATORY LOOP
By Antonio R. Walker, B.S. in Biomedical Engineering

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Biomedical Engineering at Virginia Commonwealth University.

Virginia Commonwealth University, 2010
Director: Gerald E. Miller, Ph.D.
Department Chair of Biomedical Engineering

Valvular heart disease (VHD) continues to have significant effects on many people’s lives, with
numbers expected to grow tremendously over the next few years. Individuals suffering from
severe valvular heart disease usually require a heart valve transplant in order to restore the native
valve’s vital unidirectional flow regulation. Therefore, artificial heart valve (AHV) research is of
very high importance. Previous research studies have provided substantial input in the realm of
AHV design relative to durability, thrombotic and hemolytic potential, and overall functionality.
However, modifications continue to be warranted due to limitations in the accuracy and time
efficiency of the in vitro physiological flow replication process.

The objective of this

investigation is to develop and analyze a method of AHV performance evaluation using a novel

xi

test chamber within an automated mock circulatory loop. The constructed mock loop was
designed to maintain consistency of current industrial and academic research systems while
providing innovative loop component control that allows for run-time changes and performance
screening to various physiological conditions. Pressure sensors, ultrasonic flow meter, process
controls and mechanical feedback sensors are managed via Labview in order to provide
sufficient real-time performance analysis during system operation. In addition, a unique
mechanical heart valve (MHV) test chamber was constructed to incorporate the test AHV in the
mock loop flow path. This research exposes a test tilting disk MHV to a series of 12 heart rate
and stroke volume combinations so as to evaluate the system’s effectiveness in pathological
condition replication with respect to AHV design research. A Particle Image Velocimetry (PIV)
system was utilized to illuminate particles in the flow field and obtain representative vector plots.
Results of this study validate the combined experimental test chamber and automated mock
circulatory loop as a viable MHV performance evaluation system by using real-time pressure and
flow data to analyze system fluid dynamics at the MHV test site. Consequently, the use of this
arrangement in MHV performance analysis greatly improves upon time restraints and accuracy
concerns associated with currently used manually controlled setups.
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1 INTRODUCTION

1.1 Motivation and Significance
Nearly 4.9 million Americans presently suffer from heart failure with over 500,000 new
patients diagnosed each year [1]. Consequently, cardiovascular heart disease (CHD) is the
leading cause of death in the United States, fatally affecting approximately one person every 34
seconds [2]. While these statistics alone are reason for alarm, concern is heightened by evidence
of similar trends worldwide. Therefore, as the number of people suffering from CHD continues
to grow, so does the significance of research focused on cardiological deficiencies. One
particular group of ailments, known as valvular heart disease (VHD), provide the impetus for this
research and support the broader theme of finding novel solutions to cardiovascular disorder
prevention and treatment.
VHD affects more than 100 million people worldwide and accounts for 10% to 20% of
all cardiac surgical procedures in the United States [3]. In addition, there are currently over
290,000 surgical heart valve procedures conducted globally each year [4] with, roughly, onethird of those being in North America [5]. This global total is expected to exceed 850,000 by the
year 2050 [4], which denotes an annual percentage rate increase of 10-12%. As a direct result of
the realities associated with these growth estimates, the prominence of heart valve exploration
will progressively increase and, thus, provide an ever expanding contribution to society.
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1.2 Function and Anatomy
Heart valves control the unidirectional blood flow through the heart and, consequently,
can have major effects on the overall efficiency of the entire cardiovascular system. They are
facilitated via the formation of pressure gradients during each heart cycle which cause them to
open and close as appropriately intended.
There are four major valves in the human heart, excluding the coronary sinus and inferior
vena cava valves. The tricuspid and bicuspid valves are the atrioventricular (AV) valves that lie
between the respective atria and ventricles. The pulmonary and aortic valves are classified as
semilunar (SL) valves and are located between the ventricles and exit arteries. Each side of the
heart, right and left, contains two valves, one AV and one SL.

1.2.1 Right Side of the Heart
The right side of the heart transports CO2 rich
blood through the pulmonary cycle for oxygenation. The
right atrium serves as the collection container for
deoxygenated blood from the superior and inferior vena
cava after it successfully undergoes systemic circulation
through the body. Following blood return into the right
atrium, blood moves into the right ventricle.

During

systole, the right ventricle pumps blood through the

Figure1.1. [6] Right heart anatomy.

pulmonary arteries and down to the lungs for CO2-O2 gas exchange via diffusion. The right heart
contains the tricuspid AV valve (controls flow from right atrium to right ventricle) and the
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pulmonary SL valve (controls flow from the right ventricle into the pulmonary arteries). Figure
1.1 depicts blood flow through the right heart.
The normal tricuspid valve possesses three leaflets connected to three papillary muscles
by chordae tendineae located in the right ventricle. The papillary muscles and chordae tendineae,
subvalvular apparatus, do not affect
valve function and primarily help hold
the tricuspid valve in place using
tension

to

provide

stability.

The

tension also stops prolapse of the
leaflets into the atrium, maintaining a
tight seal. The tricuspid valve opens
when the pressure of the right atrium
surpasses the pressure in the right
Figure 1.2. [7] Tricuspid (Red) and Pulmonary (Yellow)
valve orientation.

ventricle. This occurs during atrial

contraction, ventricular diastole. At the beginning of right ventricle contraction, ventricular
systole, blood attempts to flow back into the atrium. It is this flow, in conjunction with
intraventricular pressure, which pushes against the valvular flaps causing the triscupid valve to
close.
The pulmonary valve has three cusps. It opens during ventricular systole when right
ventricle pressure exceeds pulmonary artery pressure. Similarly, pulmonary valve closure occurs
at the end of the systolic cycle when right ventricular pressure quickly drops, allowing pressure
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in the pulmonary artery to once again become the larger of the two. Figure 1.2 illustrates
pulmonary and tricuspid valve orientation, relative to the right heart chambers.

1.2.2 Left Side of the Heart
The left side of the heart is the pumping mechanism for systemic circulation. It drives
oxygenated pulmonic blood through the aorta and out to
the tissues, muscles, and end organs where it undergoes
O2-CO2

gas

exchange.

Blood

exiting

pulmonary

circulation fills the left atrium, which then passes on to the
left ventricle and, finally, out the aorta. The left heart
encloses the bicuspid AV valve (controls flow from left
atrium to left ventricle) and the aortic SL valve (controls
flow from the left ventricle into the aorta). Figure 1.3

Figure1.3. [6] Left heart anatomy.

navigates blood flow through the left heart.
The bicuspid valve (commonly known as the mitral valve) has two leaflets and typically
occupies an area of 4-6 cm2. The valve orifice is surrounded by a ring of fibrous tissue called an
annulus. Like the tricuspid valve of the right heart, the mitral valve leaflets are attached to
papillary muscles by chordae tendineae in the left ventricle. The mitral valve opens due to
increased pressure from the left atrium as it fills with blood, which causes pressure increases
above that of the left ventricle and allows blood to flow through the valve. The initial surge of
blood occurs during early left ventricular diastole and accounts for 70-80% of the total filling of
the ventricle (called early rapid filling). The other 20% of complete left ventricular volume
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comes from atrial contraction (atrial systole), which drives the remaining blood out of the left
atrium. Valve closure ensues at the end of atrial contraction to prevent blood backflow.
The normal aortic valve contains three cusps, resembling the pulmonary valve. During
ventricular systole, pressure rises in the left ventricle. When the pressure in the left ventricle rises
above the pressure in the aorta, the aortic valve opens, allowing blood to exit the left ventricle
into the aorta. Once ventricular systole
ends, pressure in the left ventricle rapidly
drops. The decrease in left ventricular
pressure enables the force of the aortic
pressure to close the aortic valve. Figure
1.4 illustrates aortic and mitral valve
orientation, relative to the left heart
chambers.
Figure 1.4. [7] Mitral (Green) and Aortic (Blue)
valve orientation.

Identical to the right side, the lower

ventricle on the left side of the heart is thicker and stronger than the upper atrium. However, the
muscle wall surrounding the left ventricle is more bulky than the right ventricle, which makes the
left ventricle more physically powerful. This difference allows the left side of the heart to
provide a greater amount of force to successfully push the heavier, nutrient-rich blood through
the longer systemic circulation. Using the general formula: WORK = FORCE X
DISPLACEMENT, the greater force and longer distance of blood travel produced by the left side
of the heart implicates a superior workload. Due to this massive difference in workload between
the two sides, the left heart components are subjected to more strenuous circumstances than
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those of the right. As a result, left heart valves have an increased potential for failure. Thus, the
majority of the previously noted 290,000 global surgical heart valve procedures [4] attempt to
correct mitral and aortic valve complications on the left side of the heart.

1.3 Pathologies and Diagnoses of Left Heart Valve Disease
In cases of heart valve disease, problems arise when normal regulatory functionality of
the valve is disrupted, leading to disturbances in blood flow [2, 8]. The primary diagnoses of
heart valve disease include the incidence of stenosis, regurgitation, or a combination of the two.
Stenosis occurs when the valve fails to open completely and fails to transfer the standard amount
of blood through the opening. Regurgitation is the leakage of blood back through the valve in the
reverse direction due to improper prevention of backflow. Both diagnoses have the potential to
instigate additional cardiovascular complications, including failure and/or blood seepage into the
lung.

1.3.1 Mitral Valve Heart Disease
1.3.1.1 Mitral Stenosis
Mitral stenosis is characterized by the narrowing of the mitral valve orifice within the
heart. When the mitral valve area shrinks below the normal 4-6 cm2, specifically below 2 cm2,
blood flow into the left ventricle is blocked, creating an abnormal pressure gradient increase
across the mitral valve. This gradient is multiplied as the heart rate or cardiac output rises, which
also raises the necessary amount of time needed to completely fill the left ventricle with blood.
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As the heart rate increases, ventricular diastole decreases along with the amount of time needed
for the ventricle to fill (diastolic filling period). Therefore, once the heart rate reaches a certain
threshold, the diastolic filling period is insufficient to fill the ventricle with blood and pressure
builds up in the left atrium, leading to pulmonary congestion. Severe mitral stenosis occurs when
the orifice is less than 1 cm2 and is often characterized by a pressure gradient across the mitral
valve of more than 10 mmHg [9]. Meaning a pressure gradient of 20 mmHg, coupled with a
normal left ventricular diastolic pressure of about 5 mmHg, results in a left atrial pressure of
about 25 mmHg. Atrial pressures of this caliber lead to a variety of other complications including
pulmonary hypertension, pulmonary edema, and atrial fibrillation [3, 9]. Furthermore, the
accelerated heart rate joined with the shortened diastolic time produces a decreased cardiac
output, often resulting in sudden congestive heart failure.
1.3.1.2 Mitral Regurgitation
Mitral regurgitation is the abnormal leaking of blood from the left ventricle, through the
mitral valve, and into the left atrium during left ventricular systole. It can be brought on by a
malfunction of any of the mitral valve components, leaflets, annulus, chordae tendineae, or
papillary muscles, and occurs in three phases, acute, chronic compensated, and chronic
decompensated.
Acute mitral regurgitation causes an abrupt volume overload of both the left atrium and
the left ventricle. The left ventricle develops volume overload because with every contraction it
pumps blood into the aorta (forward stroke volume), while blood regurgitates back into the left
atrium (the regurgitant volume). The total stroke volume of the left ventricle (forward stroke
volume plus regurgitant volume) increases with more regurgitation, which raises the percentage
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of blood pumped from the left ventricle during one heart beat (ejection fraction). This increased
ejection fraction deteriorates the left ventricular contractile function over time and thus
eventually leads to a dysfunctional left ventricle with a decreased ejection fraction [10]. In
addition, the regurgitant volume causes a volume and pressure overload of the left atrium, which
inhibits drainage of blood from the lungs via the pulmonary veins and causes pulmonary
congestion [10].
Chronic compensated mitral regurgitation develops slowly. It is characterized by
thickening of the left ventricle wall (hypertrophy) as an attempt to compensate for the larger than
normal stroke volume. This hypertrophy, in conjunction with an increased diastolic volume,
increases the stroke volume to higher than normal levels. As a result, the forward stroke volume
approaches the normal levels in spite of the regurgitant volume. The volume overload of the left
atrium causes enlargement of the left atrium chamber. The increased chamber size allows the left
atrium filling pressure to decrease. This improves the drainage from the pulmonary veins and
lowers the signs and symptoms of pulmonary congestion. So, these changes in the left ventricle
and left atrium improve the state of the low forward cardiac output and the pulmonary
congestion that occur in acute mitral regurgitation. Frequently, patients diagnosed with chronic
compensated mitral regurgitation do not exhibit symptoms of regurgitation [10].
Individuals with advanced stage chronic compensated mitral regurgitation are diagnosed
with chronic decompensated mitral regurgitation. It is characterized by overload of the left
ventricular contractile elements, calcium within the cardiac myocytes, resulting in left ventricle
dysfunction [3, 10]. The ventricular muscles, myocardium, lose the ability to adequately contract
and cannot compensate for the volume overload associated with mitral regurgitation.
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Subsequently, the left ventricle stroke volume decreases and forces an increase in the endsystolic volume that translates to increased filling pressures of the ventricle. This once again
leads to increased pulmonary venous congestion, which often results in symptoms of congestive
heart failure. Furthermore, the left ventricle widens and causes an enlargement of the mitral
valve annulus, which may worsen the degree of mitral regurgitation [10].

1.3.2 Aortic Valve Heart Disease
1.3.2.1 Aortic Stenosis
Aortic stenosis transpires when the aortic valve narrows and prevents blood flow from
the left ventricle to the aorta. It causes an increased pressure gradient between the left ventricle
and the aorta. The more constricted the valve, the higher the pressure gradient. To compensate
for the elevated pressure gradient, the left ventricle generates an increased pressure to drive
blood into the aorta. This pressure overload results in left ventricle hypertrophy and, over time,
produces a decline in systolic function. Aortic stenosis is the most prevalent form of
cardiovascular disease in the Western world after hypertension and coronary heart disease [3].
1.3.2.2 Aortic Regurgitation
Patients suffering from aortic regurgitation experience blood leakage in the reverse
direction of the aortic valve during ventricular diastole (from the aorta into the left ventricle). It
is usually caused by abnormalities of either the aortic valve or the aortic root. When the pressure
in the left ventricle falls below the pressure in the aorta, the aortic valve is not able to completely
close, which means that forward stroke volume blood regurgitates back into the heart. The
percentage of blood that flows back through the aortic valve due to stenosis is known as the
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regurgitant fraction [3]. This causes a decrease in the diastolic blood pressure in the aorta, and,
therefore, an increase in the pulse pressure (systolic pressure minus diastolic pressure). It
ultimately leads to both a volume (elevated preload) and pressure (elevated afterload) overload
of the heart. The pressure overload causes left ventricle hypertrophy and could eventually lead to
more serious complications.

1.4 Treatment of Left Heart Valve Disease
1.4.1 Valve Repair
Stenosis and regurgitation can generally be corrected via surgical procedures that either
enhance blood flow, stenosis, or rectify closure inefficiencies, regurgitation. Most valve repairs
conducted on the left heart involve the mitral valve and the applied surgical procedure ultimately
depends on the diagnosis. Mitral valve repair techniques generally include:
•

Commissurotomy removes blood flow blockage caused by enlarged leaflets that
may stick together. Surgery consists of severing the leaflets at their bonding point,
which reopens the orifice and allows normal function to ensue.

•

Vavuloplasty is a reinforcement procedure that restores the complete closing
ability of the valve. Annulus dilation is combated by implanting a cloth-covered,
ring-like mechanism around the native annulus to provide support and return it to
its original size. This brings the leaflets back into contact with each other.
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•

Reshaping compensates for leaflet elongation by a method commonly referred to
as quadrangular resection. Unneeded, loose leaflet segments are removed and the
remaining leaflet is sutured so as to fix closing complications.

•

Decalcification eliminates the calcium buildup from the leaflets and/or annulus,
which increases the orifice area and restores function.

•

Chordae tendineae repair or replacement re-establishes the structural support
of the valve by surgically shortening or using synthetic material, Gore-Tex, to
replace the native chordae tendineae. Chordae tendineae may lose tension due to
stretching or failure of papillary muscle function, but material length and function
restoration permits valve closure.

•

Patching uses tissue sections to conceal valve apertures in the leaflet and/or
annulus.

Of these methods, only commissurotomy and decalcification are utilized in treatment of stenosis.
Furthermore, more recent research focuses on the adaptation of percutaneous repair techniques
[2, 11]. Several of these methods can also be used in aortic valve repair; however, they are
infrequently attempted because of the technical difficulty involved.

1.4.2 Valve Replacement
Despite the success of left heart valve repair, patients with severe physiological
impediment face complete native valve replacement as the only viable solution. Consequently,
these “one solution” scenarios escalate the significance of effective replacement valve
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development [2]. Since the first successful heart valve replacement procedure in 1952 by Dr.
Hufnagel, there have been over 4 million, 300,000 annually, prosthetic replacement implants
worldwide of over 50 developed artificial heart valve designs [4, 5]. These designs have
effectively advanced the realm of heart valve research and are categorized into two major
divisions, biological and mechanical.
1.4.2.1 Bioprosthetic Valves
Bioprosthetic replacements include, but are not limited to, valves taken from human
donors

as

well

as

specified

animals. The most widely utilized
bioprosthetic valves have porcine
origins or are constructed from a
sheet of bovine pericardium that
is cut to form valve leaflets and
sewn into the valve structure [5].
The first commercial porcine
valve was the Hancock valve
introduced in 1970. Since then
additional bioprosthetic valves
have been developed, using a
variety

of

other

biological

Figure 1.5. [5] Different models of bioprosthetic heart valves.
(A)Medtronic HK II ultra porcine valve (with permission from
Medtronic Inc). (B)Medtronic Freestyle porcine valve (with
permission from Medtronic Inc). (C)Carpentier-Edwards
Perimount bovine pericardial valve. (D)Edwards SAPIEN
transcatheter pericardial aortic valve (courtesy of Edwards
Lifesciences LLC, Irvine, CA, USA).

material. They include bovine pericardial valves, Carpentier-Edwards Perimount, and equine
tissue valves, original Cribier-Edwards. The Carpentier-Edwards Perimount valve is the only
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pericardial valve widely available in North America [5]. Most bioprosthetic valves are preserved
in glutaraldehyde and mounted on a metal or plastic covered frame/stent with fabric that acts as
the sewing ring. In cases where a larger than normal valve orifice is required, stentless
bioprosthetic valves are used. These valves lack a stent/frame as part of their structure and thus,
provide a larger effective orifice area and lower postoperative transvalvular gradients, compared
to stented valves. In contrast to mechanical valves, bioprosthetic valves mimic native heart valve
operation by providing unobstructed central flow. Figure 1.5 shows some well-known
bioprosthetic valves.
1.4.2.2 Mechanical Valves
Currently, there are three
main

classes

of

mechanical

valves, caged-ball, single leaflet
or

tilting-disk,

and

bileaflet

valves. They are all comprised of
three main elements: a closure
mechanism (occluder), housing,
and

sewing

ring.

The

first

prosthetic heart valve was the
Figure 1.6. [5] Different models of prosthetic mechanical heart
valves. (A)Starr-Edwards caged-ball valve (courtesy of Edwards
Lifesciences LLC, Irvine, CA, USA). (B)Bjork-Shiley tiltingdisk valve (courtesy of Sorin Group of Canada Inc, Canada).
(C)Medtronic Hall tilting-disk valve (with permission from
Medtronic Inc, Canada). (D)St Jude Medical Regent bileaflet
valve (courtesy of St Jude Medical Canada).

Starr-Edwards caged-ball valve
introduced in 1960. The original
version of the Starr-Edwards
valve utilized a free-ball design
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with a silicone rubber (silastic) ball that freely moved inside a three-strut alloy cage. Subsequent
models had a metal ball and a four-strut cage. Following the Starr- Edwards caged-ball design,
the single leaflet or tilting disk valve was pioneered in 1969 by Bjork-Shiley. It consists of a
pyrolytic carbon disk that is stabilized by a large inflow and small outflow alloy strut and
enclosed by a Teflon sewing ring. The Medtronic-Hall tilting-disk valve remains one of the most
implanted valves of all time [5]. Even more utilized than the Medtronic-Hall tilting-disk valve is
the St Jude Medical valve introduced in 1977 [5]. It was the first bileaflet valve and is made of
two pyrolytic carbon coated leaflets, with graphite, that pivot on a ring and is encircled by a
sewing ring. The St Jude Medical bileaflet valve is the single most implanted mechanical valve
to date [5] and has been modeled to form several other commercially available bileaflet designs.
Consequently, bileaflet valves are the most commonly used of the three main classes [5]. Figure
1.6 shows some of the more prominent mechanical valves.

1.5 Disadvantages of Prosthetic Heart Valve Implantation
Bioprosthetic valve replacements have exceptional histocompatibility, but are susceptible
to problems attributable to natural degenerative effects [12]. Subjects who receive biological
valve replacements often experience a recurrence of issues dealing with regurgitation or
calcification, which often require additional surgery to repair or replace. For this reason, most
bioprosthetic valves last approximately 15 or so years after implantation, making durability the
major concern.
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In contrast to bioprosthetic valve replacements, mechanical valve replacements have little
to no durability concerns. On the other hand, mechanical valves lack the excellent histologic
characteristics of bioprosthetic valves [12]. As with the implantation of all foreign devices in the
circulatory system, it is essential for mechanical heart valve replacements to keep normal blood
flow disruption to a minimum. For this reason, patients with mechanical heart valves must
constantly take blood thinner to reduce the potential of blood clot formation in and around the
replacement valve. Research shows the chief factors that influence thrombus development are
changes in vessel wall morphology, changes in blood flow through the vessel, and changes in
blood composition [13, 14]. Since blood composition usually remains constant before, during,
and after mechanical valve replacement surgery, the remaining two factors are the foundation of
clot formation at the replacement site. Coincidentally, both morphology and blood flow
variability depend heavily on the design of the replacement [15]. The morphology of the
mechanical replacement valve does not change following fabrication; however, flow variability
within the valve is a product of its morphology. Sudden changes in flow dynamics tend to have a
negative impact on red blood cells by causing incidences of turbulent flow and flow separation.
At these locations of flow disturbance, an amplification in the stress on red blood cells is noticed,
which often lead to rupture (hemolysis) and platelet aggregation. Research support the use of
certain design types over others based upon the design’s tendency to prompt flow turbulence
[16]. Therefore, the way to control thrombus activity in the mechanical replacement valve is to
incorporate design specifications that theoretically induce laminar flow while minimizing flow
disturbances such as turbulence and flow separation. Furthermore, study results indicate area
specificity in blood clot formation of existing mechanical heart valve replacement designs,
especially at the struts of caged-ball and tilting disk valves and the hinges of bileaflet valves
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[17]. These research results designate exact interest areas for improvement purposes and
progression towards the continual goal of ideal histocompatibility, which implies little to no
blood clot formation. Evidence of prior research confirms that, of the three chief mechanical
models, bileaflet valves experience the least amount of clot formation. However, hemolysis and
thrombosis continue to be major issues of concern in all mechanical heart valve (MHV)
replacement designs.
Both biological and mechanical prosthetic heart valves have made enormous progress
over the years; however, improvements continue to be warranted because of shortcomings that
include durability and the propensity to incite thrombosis and/or hemolysis [18]. The ideal,
functional replacement valve will maximize biocompatibility while also minimizing longevity
and histologic concerns.

1.6 In Vitro Evaluation of Prosthetic Heart Valves
In the case of MHV replacements, advancement towards an ideal design primarily centers
on the evolution of proven existing, operable models. Researchers continuously search for ways
to improve these models via the study of things such as prosthetic valve geometry and
manufacturing material. Likewise, there is a constant need to assess flow when using newly
renovated bioprosthetic heart valves. In order to investigate these various artificial heart valves
prior to implantation, it is necessary to recreate the natural valve in in vivo conditions so as to
better assess the biofluid dynamics. Therefore, the enduring pursuit of the ideal heart valve
design is accompanied by the ever-changing development of an in vitro testing environment that
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effectively simulates in vivo conditions. As previously stated, the majority of valve replacement
procedures occur on the left side of the heart. For that reason, much of the valvular research
concentrates there as well. These analyses serve as a method of evaluating the effects of the
prosthetic valve biofluid dynamics on hemolytic and thrombotic activity before patient insertion.

1.7 Research Aims
Currently there exist several devices used to assess MHVs in a variety of mock
circulatory loop setups. These tools readily provide information for in vitro MHV performance
evaluation, including but not limited to thrombosis, hemolysis, and material failure. Translation
of these concepts into a mechanism that allows for quicker and more efficient MHV
interchangeability and hemodynamic condition manipulation will potentially improve upon the
required time needed for assessment and comparative testing. The purpose of this research is to
develop and validate an instrument and procedure for evaluating MHV replacements in the
Artificial Heart Laboratory at Virginia Commonwealth University. The goals of this research
include:
•

Design and construction of a quick, interchangeable MHV holding chamber

•

Implementation of the MHV holding chamber into a fully automated mock
circulatory loop

•

Visualization of fluid flow through the test MHV at varying physiologic
conditions
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2 LITERATURE REVIEW

Over the years, a major focal point of valvular investigation has been the effective
performance testing of artificial heart valves (AHV) using proficient simulation of the native left
heart environment. Several studies have been conducted to determine the causes and locations of
valvular induced flow disturbances that may lead to hemolysis or thrombosis. These studies have
been done on both FDA approved and unapproved designs as well as in comparative analyses
that provide evidence of the advantages of one particular design over another. These research
approaches have provided groundbreaking information used in AHV design.

2.1 History of AHV In Vitro Test Results
One major concept that was investigated early was the clinical affects of regurgitant
backflow and low cardiac outputs on AHV performance. Meyer et al [19] and Kini et al [20]
have completed numerous experimental procedures on regurgitation backflow. They used their
findings to effectively predict regurgitant leakage flow regions and correlated these locations
with high magnitudes of Reynolds shear stress, which has been found to be a major factor in
hemolysis. Similarly, Sabbath and Stein [21] conducted comparative analyses of four AHVs in
order to investigate backflow and its relation to other cardiac elements. They stated that valve
closure and leakage contribute, independently, to total valvular backflow measurements and
primarily focused on the association between the amounts of total backflow of examined
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prosthetic aortic valves when exposed to specific mean aortic pressures. Furthermore, they
presented evidence of the effects of cardiac output on backflow and provided response
measurements to changes in heart rate and/or stroke volume. They deduced that the risk of
clinical significance is heightened when exposed to lower cardiac outputs, which was further
explored by researchers such as Z. Wu and company. Wu et al [22] evaluated AHVs during low
cardiac output conditions and found that valve size and closure volume were directly related to
one another, meaning that increasing or decreasing one induces a similar response in the other.
Therefore, designing AHVs with this in mind allows normal valve functionality at lower cardiac
outputs. These studies advanced the significance of in vitro AHV evaluation under low cardiac
output conditions and support the importance of regurgitation backflow. As a result, they greatly
contribute to AHV design progression.
Another notable investigative dynamic of valvular-induced fluid mechanics is the
analyses of vortex and microbubble formation. Gross, Shermer, and Hwang [23] focused on flow
fields distal to the prosthetic heart valve. They concluded that the distal flow was affected by
valvular opening angle by relating the valve leaflets to a set combination of rectangular plates
and utilizing prior airfoil studies to characterize them. Thus, factors such as drag force, lift
coefficient, drag coefficient, and momentum coefficient were used to analyze the observed distal
flow patterns and explain boundary layer flow separation at the end of the valve leaflet. The
establishment of this relationship between the valve leaflets and earlier validated airfoil
evaluations allowed Gross, Shermer, and Hwang to realize a trend stating that increased opening
angle leads to increased flow separation and vortex shedding (i.e. turbulence). Moreover, Milo et
al [24] expanded on Gross and company’s research by linking observed vortex regions to clinical
complications such as left atrial wall mechanical damage, thrombotic issues, and inflammatory
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reaction effects. In addition, they verified the isolated existence of microbubbles at mechanical
valve closure and connected the event to the valve shutting process. These bubbles enhanced the
potential of the blood to clot and made these locations, local and abroad, more susceptible to
thrombosis. Conclusively, the observed results of these research endeavors, along with their
clinical implications, were very important to AHV performance testing and led to improvements
in future design and operation.
Lastly, a principle clinical concern of heart valve analysis is the development of
cavitation. Johansen et al [25] Manning et al [26] conducted an in depth analysis of vortices and
regurgitant jets during the closure and rebound phases of MHV operation. They were able to
associate these phenomena with potential cavitation growth and clinical implications based upon
prior investigative studies done by others. One such prior investigative study was performed by
Lamson et al [27]. Their research involved AHV cavitation pattern detection in real-time.
Through this real-time detection process, they were able to characterize areas of replicating
cavitation formation and develop a cavitation cycle that corresponds with that of the normal
cardiac cycle. In addition, they plotted this cavitation cycle as a function of atrial pressure. The
techniques developed in this study provided a means of exposing the causes and locations of
cavitation formation during the usage of AHVs, which helps in the design and implementation of
cardiac heart valves, drive systems, and/or device control schemes.
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2.2 AHV Experimental Test Setups
As stated above, a major component of the previously described research was the
simulation of the native left heart environment. Several AHV assessment mechanisms only seek
to reproduce natural flow conditions and do not take into account other anatomical feature
effects. The majority of studies that employ this type of arrangement are focused on the
performance of a particular AHV at very specific conditions and locations. However, for
researchers that want to better replicate human physiology, a typical experimental setup consist
of a mock circulatory loop in conjunction with an image capture apparatus. The common theme
of these systems is their attempt to imitate native conditions so as to expose the trial AHVs to
circumstances similar to those encountered after implantation. However, they have evolved over
the course of time due to variability in study focus.

2.2.1 AHV Test Chamber
An investigator’s AHV test system is heavily based on the intended goals of their
experimentation. For instance, Browne et al [28] neglected common components such as
compliance and peripheral resistance. Consequently, the primary observation area of their
experimental setup consisted of flow, supplied by a centrifugal pump, through a mounted AHV
and into a clear, anatomically correct aortic root model where imaging was completed. Figure
2.1 shows the Browne et al AHV test system. In this study, Browne et al were more focused on
the imaging technique so the test arrangement was indicative of that focus.
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Other examples of this type of arrangement were Meyer et al [19] and Kini et al’s [20] “single
shot” chamber system shown in Figure 2.2. These groups sought to supply an all-inclusive
interpretation

of

mechanical

heart valve flow fields with
both global and localized data
[19, 20]. These experimental
objectives permitted a fairly
simplistic test chamber setup
that

consisted

of

a

two

compartment box connected on
one side by a mechanical heart

Figure 2.1. [28] Diagram of mounted test valve and anatomically
designed aortic model in Browne et al’s experimental setup.

valve mounted in a constructed valve holder. The ventricle was represented by the smaller
compartment, which was sealed and linked to a pneumatic pressure regulator system, and the
atrium was the larger chamber that was open to the atmosphere. The pressure was controlled in
the ventricular chamber so as to simulate the physiological systolic cycle where pressure was
held constant to symbolize systolic duration and then released.
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Figure 2.2. [19, 20] Diagrams of Kini et al MHV test setup, Top View (top left) and Side View (top right).
Diagram of Meyer et al MHV in mounting arrangement (bottom).

Correspondingly, the test arrangement employed by Milo et al [24] for vortex evaluation was
manufactured to imitate fluid flow during early systole, at the point where backflow is at its peak
and immediately following heart valve closure. More specifically, they wanted to recreate the
high velocity leakage through the narrow gap of the closed leaflets. To accomplish this, the
experimenters used a single test chamber with a static valve mounted in the closed position and
controlled fluid flow via a high-speed solenoid valve that connected to a regulated pressure
basin. In addition, a microbubble generator was attached to the test chamber to produce hydrogen
bubbles that served as tracers for vortex visualization. Milo et al’s experimental AHV test
chamber is depicted in Figure 2.3.
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Validation from prior literature
supports the use of these arrangements
in these scenarios and, thus, defends the
significance of the acquired data in
AHV performance research. However,
Figure 2.3. [24] Milo et al AHV test chamber.

it is recognized that these setups do not adequately depict the pulsatile flow or the peripheral
resistance of the native cardiac system. Both of which notably affect blood flow.

2.2.2 Mock Loop Testing
Despite the success of the above mentioned studies, several researchers prefer the
application of a more physiologically correct understanding. An early in vitro test arrangement,
based on a larger version introduced by Davila, Trout, Sunner, and Glover in 1956, was utilized
by Bjork, Intonti, and Meissl [29] to examine prosthetic mitral and aortic valves. In choosing this
system, Bjork et al placed heavy emphasis on the ability to accurately simulate a variety of
physiological conditions. The system contained a mechanical pulse duplicator and was equipped
with the capability to adjust systolic-diastolic range and ventricular, atrial, and aortic pressure
curve shape. The pulse duplicator, shown in Figure 2.4, had a closed loop arrangement with two
independent, hydraulic components: 1. pumping system and 2. testing system. The pumping
system consisted of a one-armed roller pump that regulated stroke volume and pulse rate via the
manual control of RPM and tube occlusion. The testing system was the interconnected valve
testing chambers, aortic analogue, peripheral resistance, and left atrium analogue. Manual
mechanical adjustments of the testing system included changeable peripheral resistance and the
height of the reservoir above the mitral valve chamber.
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Bjork, Intonti, and Meissl utilized the
positive outcome of this experiment to help
establish the importance of simulating left
ventricular,

left

atrial,

and

aortic

physiological dynamics during in vitro
evaluation of mitral and aortic cardiac
valves. As a result, numerous ensuing AHV
studies employed similar mock loop setups.
These latter studies often had relatively
Figure 2.4. [29] Pulse duplicator. L.A.=left atrium;
M.V.=mitral valve; L.V.=left ventricle; A.V.=aortic
valve; A=elastic container; B=rigid container;
P=pump; P.R.=peripheral resistance.

minor modifications such as a human-shape
molded, collapsible rubber sac for the left

ventricle and a calf aortic root mold with the Sinus of Valsalva in place of the aortic analogue
[21]. In spite of these modifications, the system consistently produced overall static performance
results.
Eventually, as a better understanding of natural cardiovascular simulation was developed,
several elements of the aforementioned mock circulatory loop were eliminated. Conversely, new
components were added such as programmed waveform generators [30]. Johansen et al [25] used
a mock loop with an Electric Ventricular Assist Device in conjunction with mechanisms to
simulate atrial and venous compliance. While these compliance chambers were not found in the
Bjork et al setup, Johansen et al also utilized identical key features such as systemic resistance
and a venous reservoir. Pressure tranducers and flow probes were positioned at specific locations
in the loop to better monitor and facilitate fluid flow. Lastly, the loop contained a bubble filter to
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remove air bubbles from the blood analog fluid that may negatively affect observation results. A
diagram of Johansen et al’s test system is seen in Figure 2.5.

Figure 2.5. [25] Diagram of Penn State EVAD and mock circulatory
loop with the location of observation equipment, filter removes air
bubbles from blood analog fluid.

Further progression of AHV test arrangements included increasingly more anatomically
correct structures. Milo et al [24] used a pulsed flow simulator with anatomically oriented
mounts for the mitral and aortic valves that functioned to reproduce physiological conditions.
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This simulator is illustrated in Figure 2.6
and was comprised of five major components, a
positive displacement pulsatile pump with a
physiologic waveform generator, a left ventricular
compartment, a couple of autonomous pressurized
containers for systemic compliance and peripheral
resistance,
reservoir

and
that

components

an open
was

through

atmosphere venous

connected
an

to

adjustable

the

other

resistance

mechanism.
The

discussed

research

provides

an

indication of the vast amounts of AHV mock loop

Figure 2.6. [24] Photograph of left heart
pulse simulator used for bubble formation
detection. LV=left ventriclular sac;
MV=mitral valve; MC=mitral channel;
AV=aortic valve; AC=aortic channel

experimental setups. Even as these systems progress, they consistently have the common primary
objective of exposing the test AHV to a range of native physiological conditions using a bench
top entity. This application is crucial to AHV design characterization. Although the described
mock loops accomplish this major system objective, there continues to be room for
improvement. The time demands and task intensiveness of manually controlling mock loop
parameters suggest significant research progression with automated mock circulatory loop
development. In reference to AHV test research, it will advance performance and comparative
test methods, especially in conjunction with an AHV holding chamber that permits speedy valve
interchangeability.
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2.2.3 Flow Visualization
During AHV mock loop and/or test chamber performance analyses, researchers utilize
several techniques to capture the observed flow field profile data. Following image capture this
information is stored and properly interpreted using a number of computer software. These
applications provide better understanding of flow as it correlates to theoretical assumptions and
assist in AHV design modification. An early method used by Lamson et al [27] included a
specialized pressure transducer to
identify valve closure and trigger a
strobe flash. The strobe flash
contained a photodiode to activate
an image capture/storage system
with a high resolution CCD
camera. In the case of this study,
the major issue with this imaging
technique was the associated time
delay. Therefore, Lamson et al had
to calculate and document time

Figure 2.7. [27] Zoom in diagram of valve, viewing port in
mock circulatory system, and instrumentation for cavitation
observation.

delays for all triggering mechanisms and the system as a whole in order to interpret the data in
real time. Figure 2.7 shows Lamson et al’s flow visualization system.
Although Lamson et al were able to use the arrangement described above, there are
several other techniques used in AHV fluid flow data acquisition, including hot-wire
anemometry, dye tracing, laser Doppler velocimetry (LDV), and particle image velocimetry
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(PIV). The latter three are based on indirect flow measurements that track an external agent
within the fluid flow, particles or dye [31]. These agents flow with the researched fluid without
differing in direction or magnitude from the fluid velocity, which allows for accurate recordings
[31]. Hot-wire anemometry uses temperature and electrical resistance.
2.2.3.1 Hot-Wire Anemometry
Hot-wire anemometry is a relatively easy and inexpensive technique that provides
extremely high frequency-response and fine spatial resolution; however, the utilized devices are
exceedingly delicate. Hot-wire anemometers are devices used to measure the variables occurring
in turbulent flows, such as mean and fluctuating velocity components, mean and fluctuating
temperature, etc. The sensors are thin metallic elements heated by an electric current and cooled
by the incident flow, which acts by virtue of its mass flux and its temperature. From the
temperature (or resistance) attained by the sensor, it is then possible to deduce information on the
flow. More than one sensor, or more than one value of the heating current, is often necessary to
investigate thoroughly a turbulence flow [32].
2.2.3.2 Dye Tracing
Dye tracing uses dye or a chemical reaction to track fluid flow in order to analyze flow
patterns. This visualization method provides qualitative data and works best with laminar flow
profiles that maintain streamlines for imaging [33]. Turbulent flow profiles mix the dye lines and
make characterization very difficult. Dye tracing requires using dye that follows fluid flow
without incident, meaning that it has the same density as the investigated liquid [33]. The dye is
also injected into the flow field at a rate that is proportional to the fluid velocity [33]. Sometimes
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photo dyes are used that fluoresce when encountered by light [33]. Images are captured using a
high speed camera to measure the travel distance of the dye.
2.2.3.3 LDV and PIV
The advantages and disadvantages of the LDV and PIV methods have been heavily
examined. Browne et al [28] conducted a comparative study of these two techniques via an AHV
steady flow investigation. The setups for each process, LDV and PIV, are shown in Figures 2.8
and Figures 2.9, respectively. Three major steady flow elements, vorticity, maximum turbulent
principal stress, and maximum turbulent shear stress, were computed using previously
formulated equations and data from both the LDV and PIV processes. In comparing LDV data
and PIV data, including but not limited to contour plots, Browne et al concluded that PIV
imaging works well for purposes of gathering quantitative data in an entire flow field and LDV is
better suited for obtaining more accurate, quantitative data in specific, localized areas. They
supported this conclusion through their experimental results in which agreement between the two
imaging techniques were found in the formation of mean velocity profiles but discrepancies were
seen in areas of high turbulence, including locations of maximum normal stress and maximum
turbulent shear stress. At these turbulent regions the PIV values were significantly higher than
the LDV values; thus, presenting ambiguity when using PIV for turbulent flow applications.
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Figure 2.8. [28] Diagram of the Browne et al LDV equipment setup (left) and LDV vector density plot
(right).

Figure 2.9. [28] Diagram of the Browne et al PIV equipment setup (right) and PIV vector density plot
(left).

Based upon conclusions similar to those made by Browne et al concerning the PIV and
LDV processes, Kini and company [20] deduced that the best imaging procedure would be one
that eliminated the negative aspects of each by combining their positives. They decided to merge
the point-based LDV and the plane-based PIV to provide an extremely advantageous flow
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analysis that delivered whole-field fluid velocity information as well as high levels of accuracy
and resolution. The findings of this study included a clear, spatial illustration of flow patterns
associated with valve occluder motion during closure, rebound, and sustained leakage phases as
well as local, temporal variations in flow. These PIV and LVD interpretations were key in
determining the effects of AHV design on fluid flow, which, consequently, permits prediction of
areas that may cause in vivo hemolyisis, thrombosis, cavitation, etc. Accordingly, these LDV and
PIV imaging results defended Kini et al’s argument that the application of both techniques
enhances the ability to interpret flow information when compared to the utilization of either
technique independently.
Both the LDV and the PIV procedures are tremendously valuable in AHV performance
evaluation research. The combination of these imaging techniques supplies an all-inclusive
interpretation of AHV flow fields with both global and localized data. On the contrary, the
independent application of either LDV or PIV for flow visualization also provides very
beneficial flow data, which can be sufficient depending upon the investigative objectives. For
that reason, this research employs the independent PIV image capture method because it
provides quantitative information of the entire flow field, which satisfies the thesis goal.
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3 METHODS AND MATERIALS

3.1 Mock Circulatory Loop
As previously stated, the implementation of a mock loop to replicate the human
circulatory system is essential to AHV testing. Therefore, a mock loop was developed similar to
those utilized in prior cardiovascular research studies but with numerous modifications that
improve loop test efficiency. Figure 3.1 depicts the basic components of this mock loop which
include a tank to serve as the venous reservoir, quick disconnect mechanisms, a pump to operate
as the heart, a heart valve testing chamber, a capacitor and a resistor to represent arterial
compliance and peripheral resistance, respectively. These components are connected via 1 ¼”
outside diameter (OD) and ¾” inside diameter (ID) tubing that act as the native system
vasculature. In addition, several monitoring devices were installed in the mock loop so as to
measure a variety of circulatory system parameters. The loop is assembled in a water-resistant
wood basin that isolates the loop fluid path in case of leakage. Figure 3.1 shows the diagram and
illustration of the mock circulatory loop. With the exclusion of the heart valve test chamber,
design and implementation of these mock loop components were completed by Charles Taylor
with help from other members of the Artificial Heart Laboratory at Virginia Commonwealth
University [35].
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Figure 3.1. Mock circulatory loop.

3.1.1 Venous Reservoir
The container used as the venous reservoir is an acrylic box (6” x 6” x 6”) with ½” wall
thickness and a top open to the air. Figure 3.2 shows the acrylic venous reservoir with one inlet
and two outlet ports. The inlet port to the reservoir is centered 3” from the top edge along one of
the cube faces that lies orthogonal to the open face of the acrylic box. Outlet Port 1, labeled as
such in Figure 3.2, is located on the cube face directly across from the inlet port in the identical
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geometric position as the
inlet port on its respective
cube face. Outlet Port 1 leads
to the inlet of the pulsatile
pump. The other outlet port,
Outlet Port 2 in Figure 2.2, is
stationed

1.5”

from

the

bottom edge on an adjacent
cube face relative to the inlet
Figure 3.2. Mock loop venous reservoir.

port side. This port leads to

the inlet of the left ventricular assist device (LVAD), which, if applicable, is the steady-flow
multiple disk centrifugal pump (MDCP). The backside of the container, only face without a port,
attaches to a support laser rail. Figure 3.2 depicts the mock loop venous reservoir. The venous
reservoir is filled with fluid to a level just above the inlet, to ensure that the entire loop is
completely filled and rid of air bubbles. Adjusting the fluid level in the container and/or the
height of the container itself will vary the arterial pressure of the system. Lastly, a magnetic
stirrer is stationed beneath the venous reservoir in order to maintain a homogenous mixture when
required.
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3.1.2 Quick Disconnect System
In between each of the
outlet ports and their respective
pump is a quick disconnect
mechanism, as seen in Figure
3.3. The quick disconnects in
this mock loop serve as flow
facilitators
They

for

provide

the

system.

independent

detachment for various loop
components without having to

Figure 3.3. Mock loop quick disconnect mechanism.

drain the entire system. Each disconnect site consists of a metal on metal cam-and-groove hose
coupling in conjunction with a low-pressure PVC dual ball valve, which controls flow through
the system inner diameter. These preserve the free flow path of the mock loop, while also
allowing reasonably swift interchangeability of loop elements without complete system drainage.
As a result, the quick disconnect application reduces spillage and diminishes manual effort
commonly associated with experimental setup.

3.1.3 Pulsatile Pump
Outlet Port 1 of the system venous reservoir leads to the inlet of the pulsatile pump. The
pump in this study, which mimics heart function, is a modified Harvard Apparatus Pulsatile
Blood Pump 1423. This self-priming pump is a respected benchmark standard in hemodynamic
research that seeks to imitate the large animal cardiovascular system. It features a mechanically
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activated piston that oscillates within a clear cylinder hub. The pump design leaves minimal
blood cell damage when utilized with whole blood and completely empties the cylinder hub with
each stroke, despite the selected stroke volume. It has two caged ball valves located at the inlet,
mitral, and outlet, aortic, positions, which facilitate laminar flow through the piston-hub, left
ventricle, without incidence. The fluid flow paths of the pump can be dismantled and sterilized
when applicable. Stroke volume (SV) and heart rate (HR) are dynamically adjustable during
operation with a range of 15 to 100 mL and 0 to 95 beats per minute (BPM), respectively. This
research modeled several stroke volume-heart rate combinations at a 50% systolic ratio, where
the piston speeds during filling and emptying are identical. These varying conditions are
indicative of the wide range of physiological situations. Harvard pump modifications by Charles
Taylor et al in the Artificial Heart Laboratory at Virginia Commonwealth University include
novel conversion of manual pump adjustments to complete automation. This transformation
required preliminary computational studies in order to gain a better comprehension of the pump
motor speed profile during several HR and systolic ratio stages [35]. Observation of the pistondriving shunt motor’s voltage and current values throughout operation and the systolic/diastolic
analog feedback presented an improved understanding of the drive motor in relation to the
pumping phase [35]. These introductory investigations assisted in the selection and
implementation of a replacement motor driver board that created opportunity for external control
of the Harvard Pulsatile Blood Pump 1423. Furthermore, several novel parts were machined
and/or purchased and then applied to advance pump automation including a linear slide
potentiometer (Panasonic), Spur Gear 32 Pitch (McMaster-Carr), and Compact DC Gear Motor
12 VDC, 50 RPM (McMaster-Carr) for SV manipulation [35]. After successful pump automation
development, the system stroke volume and heart rate were calibrated accordingly. Additional
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pump alterations include removal of the silicon ball in the outlet pump valve so as to incorporate
the tilting disk MHV into the loop farther downstream, which suggests aortic valve native
orientation.

3.1.4 MHV Test Chamber
As fluid is pumped out of the Harvard pulsatile pump, it flows into the MHV test
chamber. The chamber serves as the center piece for image capture in this research. It holds the
test heart valve in position within the mock loop and allows fluid to pass through the device
mimicking blood flow from the left ventricle to the aorta via the native mitral valve. The test
chamber consists of inlet and outlet polycarbonate tube sections with a middle collar that
securely pinches the annulus of the MHV so as to anchor the valve at the designated location.
The collar was designed to operate with a 25 mm tilting disk valve, but will theoretically
function with any 25 mm MHV type. The collar is comprised of two stainless steel halves with a
1 ½” radius and 0.170” thickness. Each half contains two 100 degree countersink, #8-32 screw
through holes, which allows it to fasten to a 1/8” anchor disk that is positioned just proximal to
the valve entrance. During complete assembly, the test MHV, tilting disk valve, is wedged
between the collars and firmly attached to the anchor disk, which securely keeps the valve in the
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correct orientation. 5/16” diameter holes were created to allocate implementation with other
mock circulatory loop components
and the inlet and outlet connections.
The center hole of the collar was
constructed to mate with the outer
annulus of the valve. Figure 3.4
shows the SolidWorks model of the
collar section with the anchor disk.
The MHV test chamber inlet and
outlet features are made of 4”
Figure 3.4. SolidWorks models of 25mm valve collar (top
left), inlet/outlet MHV testing chamber (bottom left), and
exploded view of MHV testing chamber assembly (right).

polycarbonate tubing with 1 ¼”
inner diameter with 1/8” wall

thickness. This tube was fixated, using Weld-On adhesive, to a 1/8” thick, 3” diameter
polycarbonate disk with 5/16” diameter through holes for bonding to the collar using wide, flathead #¼-20 bolts with nuts. Figure 3.4 depicts the exploded SolidWorks assembly model.
Computational fluid dynamics were used to simulate fluid flow through the model prior to
manufacturing. Figure 3.5 illustrates the MHV test chamber in the mock loop. Gasket material
was placed between all contacting surfaces in order to discourage leaking incidence. In addition,
tube holders were utilized at the inlet and outlet sections to stabilize the chamber during imaging.
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Figure 3.5. Mock loop MHV holding test chamber.

3.1.5 Compliance Chamber
Following closure of the aortic valve, tension forms in the dilated aorta because of the
sudden force increase against the aortic wall
due to the abrupt change in blood volume and
pressure. This tension of the elastic vessel
wall propels blood through the circulatory
system after it is pumped from the heart. The
compliance chamber used in this experimental
mock loop is a lumped parameter that
Figure 3.6. Mock loop compliance chamber.

emulates the elasticity of all blood vessels in

the native circulatory system and is shown in Figure 3.6. When the Harvard pulsatile pump
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delivers blood to the chamber, during systole, the elastic membrane inside the chamber expands
and fluid is temporarily stored until the tilting disk valve closes to allow the pump to fill, during
diastole. The stored energy in the membrane then pushes the fluid through the loop. The
compliance chamber consists of a 5.5” hollow diameter cylinder with ¾” wall thickness and 6”
height. It splits into two sections, top and bottom. The top section contains a ½” metal plate with
a pressure valve that feeds and extracts air in and out of the top of the chamber when assembled
using a mobile air compressor. This metal plate also has a notched center that adapts with a
nonconductive composite toggle clamp that allows for a uniform compression mate of the top
and bottom chamber sections. The bottom section has inlet and outlet rigid glass tubing that
enables fluid flow in and out of the chamber, in addition to a platform that attaches to a laser rail.
Lastly, a supplementary pressure valve in the bottom section is used to expel air pockets from the
loop, if needed. During complete compliance chamber assembly, the two sections are separated
by a Thera-band membrane cartridge. The Thera-band cartridge pulsates with a consistent elastic
behavior as fluid flows through the bottom of the chamber and drives it through the loop, thus
mimicking arterial compliance. Air pressure above the Thera-band cartridge, in top chamber
section, provides resistance to Thera-band pulsation. As more air is introduced into the top
chamber via the pressure valve, opposition to Thera-band movement increases and the
membrane becomes more resistant to fluid flow. Furthermore, Thera-band flow resistance is
variable with material thickness, which is indicative of its elastic modulus. Different Thera-band
thicknesses, denoted by color, were biaxially tested for strength using a MTS machine and
developed into the interchangeable cartridges [35]. The combination of digital pressure-control
in the top chamber and Thera-band selection permits fast mock loop compliance manipulation.
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3.1.6 Resistor
The fluid resistor of the mock loop is shown in Figure 3.7 and represents the total
peripheral resistance of the circulatory system. Increasing or decreasing the resistance of the
mock loop increases or decreases the pressure in the compliance chamber, which represents
arterial pressure.
This change in arterial, aortic, pressure
modifies the pressure gradient across the
aortic

valve

(transvalvular

gradient).

A

modified transvalvular gradient is a common
indication of VHD. The resistor in this loop is
made of an aluminum rectangle (4” x 3” x 2”)
Figure 3.7. Mock loop resistor.

with a ¾” diameter tunnel to facilitate fluid

flow within the loop. This tunnel is impeded by a 1 ½” diameter solid aluminum cylinder that
translates on a path oriented orthogonally to the flow path. The cylinder is secured to a linear
stepper motor made by Anaheim Automation that internally converts rotary motion to linear
motion. In doing so it supplies a thousandth of an inch travel per step. The digital adaptability of
the motor allows for computational guidance of linearly transverse flow resistance via effective
regulation of cross-sectional area [35]. This allows for highly efficient and effective dynamic
control of the system resistance, which leads to the formation of physiological pressure
conditions indicative of a wide range of pathologies. Fluid flow through the resistor was
evaluated using computational fluid dynamics (CFD) prior to implementation [35]. Furthermore,
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the range of resistor positions was 0 to 450 with a 0 setting indicating zero flow occlusion and a
450 setting indicating complete flow occlusion.

3.1.7 Instrumentation
Several monitoring devices were present throughout the mock loop. They are used to
capture quantitative data during the experimental process such as flow velocity and pressure
value.
3.1.7.1 Flow Meter
Flow meters acquire average fluid velocity rates at particular instances in time. The flow
meter in this research was a H20XL-Sterile Tubing Flow Sensor manufactured by Transonic
Systems Incorporated and is shown in Figure 3.8. It clamps around the mock loop tubing and
employs ultrasonic transit time technology to measure the time difference of ultrasonic pulses
transmitting in and against the fluid flow direction [34]. This time difference is a measure of the
fluid average velocity along the ultrasonic beam path and can therefore be used to calculate the
averaged fluid velocity [34]. The flow sensor was calibrated to the utilized tubing and waterglycerin blood analog via an investigative test. This test consisted of a small mock loop with
reservoir and steady flow pump that drove the blood analog through a section of tubing. The
outlet of the pump emptied into a graduated beaker. A fluid volume gradient was selected prior
to pump activation start and end volumes. After pump initiation, the time it took for the analog to
rise between the start and end volume was manually measured and a flow rate was calculated
accordingly. The calculated flow rate was then compared to the calculations of the H20XLSterile Tubing Flow Sensor. This procedure was repeated 5 times and the results were averaged

44

to ensure accuracy and consistency of the method. Following linear fit to produce a calibration
formula, the entire flow sensor
calibration
repeated

method
using

a

was
higher

pumping RPM to produce a
variable fluid flow rate. The
total calibration consisted of 2
different

fluid

replicated

5

During

flow
times

mock

experimentation,

rates
each.
loop

frequency

Figure 3.8. Mock loop H20XL Sterile Tubing Flow Sensor.

responses and flow rates were acquired between the MHV holding chamber and the compliance
chamber inlet in Hertz and L/min, respectively.
3.1.7.2 Pressure Transducers
Two types of pressure transducers were inserted at numerous locations in the mock loop to
provide pressure value measurements at any given time during experimentation. These
transducers are pictured in Figure 3.9. The Omega pressure transducer (PX203-015G5V) was
utilized in a series connection between the inlet and outlet valves of the air compressor to
measure pressure levels in the top section of the compliance chamber. It has internal calibration
done by the manufacturer with confirmed accuracy. However, this internal calibration was used
to develop a calibration formula relative to the proportional opening and closing of the inlet and
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outlet pressure valves by reading displayed pressure values at correlating valve opening orifice
positions. The other pressure transducers in the loop are made by Entran Sensors and Electronics.
They are miniature sensors that are mounted flush
against the wall of glass inlet and outlet tubings of the
compliance chamber and the bottom section of the
compliance chamber. The transducer in the glass inlet
tube of the compliance chamber (99G99F22-X14)
acquires pressure measurements of fluid prior to entry
into the compliance chamber. And the sensor embedded
in the bottom section of the compliance chamber gives
pressure levels inside the chamber. The transducer
located in the outlet glass tube of the compliance
chamber was inserted but not used in this research. The
Entran pressure transducers were effectively calibrated
using a technique that formed calibration formulas from

Figure 3.9. Mock loop pressure
transducers, Entran (top) and Omega
(bottom).

acquired data relating difference in fluid volume with displayed pressure and voltage values. All
pressure sensors present data in mmHg.

3.1.8 Computer Control and User Interface
Drivers for the loop components are controlled via a single computer workstation. This
station links to an electronic control tower that houses all of the system data acquisition circuitry
and power supplies. The workstation contains the Labview 8.5.1 virtual instrument developed by
National Instruments that serves as the graphical user interface of the system. This software has a
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“dashboard” that consists of all the control buttons and simulated waveforms during loop
operation. The control tower also has the digital meters of the measurement devices installed
throughout the loop. These digital meters convert analog signals to electrical pulses which are
transformed to digital outputs via the data acquisition board. Labview uses a data acquisition
driver called NI-DAQmx to communicate with the external data acquisition board. The Harvard
pump driver utilizes a PIC microcontroller and has a serial to USB cable. The PIC
microcontroller was chosen due to its low cost, wide availability, and serial programming
capabilities. Lastly, the pressure regulator valves that control the compliance chamber pressure
have a control loop feedback mechanism known as a proportional integral derivative, PID,
controller. The PID controller calculates an "error" value as the difference between a measured
process variable and a desired set point. The controller attempts to minimize the error by
adjusting the process control inputs. Figures 3.10 shows the developed Labview control
dashboard.
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Figure 3.10. Labview control dashboard.

3.2 Blood Analog
The blood analog used in this research was a 60% water and 40% glycerin mixture. This
blend is widely utilized in mock loop flow visualization applications due to its prior-validated
ability to closely mimic real blood properties, especially density and viscosity. It has a density of
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1.122 g/mL and a viscosity of 0.00485 N-s/m2 (4.85 cP), whereas whole blood has density of
1.06 g/mL and viscosity of 0.0027 N-s/m2 (2.7 cP) [33]. Unlike whole blood, this substitute fluid
provides the advantage of being readily available while eliminating storage issues and bloodborne disease safety concerns. Furthermore, this mixture effectively follows a Newtonian fluid
characterization, which is also indicative of whole blood in most arteries [33]. For these
instances, whole blood shear stress linearly relates to deformation rate and its viscosity can be
assumed to be a constant of approximately 4 cP [33]. The blood analog was mixed in a large
glass graduated beaker by liter (600 mL water to 400 mL glycerin). In addition, the refractive
indices of the blood analog and polycarbonate tube were matched to reduce light refraction at the
test chamber-fluid interface.

3.2.1 Density
Blood analog density was effectively measured via a standard hydrometer, which is
pictured in Figure 3.11A. This instrument utilizes the Archimedes principle to determine relative
density. The Archimedes principle states that the force required to float a solid suspended in a
fluid is equal to the weight of the fluid displaced. Therefore, the lower the test fluid density then
the further down the hydrometer will sink. The procedure for blood analog density measurement
involved of pouring a specific amount of liquid into a graduated cylinder and gently lowering the
hydrometer down into the cylinder. Once the hydrometer stabilized in the blood analog fluid, the
measurement was read. The hydrometer is made of glass and consists of a cylindrical stem with a
mercury-weighted bulb to ensure upright buoyancy.
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3.2.3 Viscosity
Following calculation of blood analog density, blood analog viscosity was determined
using the density result and an Ostwald viscometer, shown in Figure 3.11B. The Ostwald
viscometer consists of a U-shaped glass tube with two bulbs and a vertical section that has a
precise narrow bore (the capillary). The smaller bulb is located above the capillary section and
the larger bulb sits towards the bottom of the other arm in the U-shaped design. The test blood
analog was drawn into the small bulb via suction and allowed to flow down into the larger bulb
using gravitational forces. Two red marks are positioned on the glass tube, above and below the
small bulb, which designates a known fluid volume. As the blood analog flows through the small
bulb, from the upper red mark to the lower red mark, the decent of the fluid level is timed via a
standard stop watch timing device. Inputting the measured flow time and the previously
calculated blood analog density into the following equation yields the blood analog kinematic
viscosity.
Viscosity (cP) = drain time (sec) * viscosity constant (cSt/sec) * density (g/mL)

Figure 3.11. Standard hydrometer (A.) and Ostwald viscometer (B.).
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3.3 PIV
3.3.1 Hardware
In this experimentation the PIV system was used for fluid flow pattern analysis. A thin
and intense laser light sheet was used to illuminate neutrally buoyant particles in a 2D flow field.
The particles scattered light from the laser which was imaged using a charged coupled device
(CCD). The PIV system combines hardware components with a software application and a
typical setup is pictured in Figure 3.12. The incorporated hardware includes a laser with power
supply, camera, synchronizer, and computer.

Figure 3.12. [33] PIV system setup.

3.3.1.1 Laser with Power Supply
The laser in this experiment is a dual mini Nd: YAG laser manufactured by New Wave
Research. It produces a doubled Q-switched beam by generating short duration (4-20
nanoseconds), high energy (12 mJ) pulsed 532 nm light. The pulse energy is high enough to
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illuminate the sub-micron particles in the water/glycerin fluid within the mock loop and the pulse
duration is short enough to freeze flow motion. The laser uses a flashlamp mechanism to produce
the pulse energy that transforms into the simulated laser beam [37]. The flashlamp firing
frequency is 15 Hz. The dual lasers are equipped with power supply units and triggers from New
Wave Research and connect to the synchronizer via color-coded connectors that denote the Qswitch and flashlamp.
The generated cylindrical laser beam is converted into a thin lightsheet using optics
located in the laser head. The optics consists of a cylindrical lens to diverge the beam in the
height direction and a spherical lens to control the lightsheet thickness. The cylindrical lens has a
negative focal length, with smaller focal lengths producing faster lightsheet divergence, while the
spherical lens focal length is usually much longer [37]. Selection of each lens is done
independently of the other and has significant effects on the lightsheet formation. Lightsheet
cross sectional area is inversely related to its intensity and light intensity is directly related to
particle illumination. So a lightsheet with large cross sectional area will not be able to expose the
particles for image capture. For optimal experimental results, the laser is positioned, relative to
the imaging area, at the focal distance of the spherical lens [37]. This focal distance is the
lightsheet thickness waist, where the lightsheet is thinnest. In addition, lightsheet dimensions
greatly influence variation in beam intensity across the imaging area. Hence, a short focal length
spherical lens produces a very thin lightsheet but a relatively large intensity gradient, which will
not create uniform particle illumination across the image area. The cylindrical lens used in this
experiment had a -15 mm focal length and the spherical lens had a 500 mm focal length with 25
mm diameter. Also the laser optics were oriented so as to produce a beam angled at 15.3 degrees
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from the horizontal. This optic tilt complimented the tilt of the CCD camera in order to create a
laser path orthogonal to the camera lens focal point, which is essential in PIV application.
3.3.1.2 Camera
The system uses a CCD camera, PIVCAM 10-30, manufactured by TSI Incorporated. It
captures pictures of illuminated particles in the fluid flow path and, in conjunction with the
computer, processes a digital image. The camera functions by converting light energy into
electrical energy and generating an electrical signal that is then sent to a Frame Grabber in the
computer, where it is digitized [37]. The digitized information is finally passed to the computer
system for processing and visualization on the monitor. The PIVCAM 10-30 obtains laser light
scattered by particles, with a maximum frame rate of 30 Hz, using a CCD array of 1008 x 1018
pixels. It contains a 550 nm filter attachment that improves imaging and maintains device
functionality via background noise filter, glare filter, and CCD saturation avoidance. The 550 nm
filter only passes wavelengths above 550 nm. Therefore, for adequate particle illumination light
must be scattered at a wavelength above this threshold to be visible [37]. Nikkon AF-Nikkor 28
mm and 50 mm lenses were used during experimentation with camera aperture setting of f/11.
Aperture selection is critical for PIV photography because it significantly affects the particle size
recorded on the CCD sensor (diffraction limited spot size), the object focus range (depth of
field), and particle illumination. Particles used in this research were manufactured by Duke
Scientific Corporation. They were hollow glass spheres with 1.05 to 1.15 g/mL density range and
8 to 12 µm mean size range. The PIVCAM 10-30 was operated in triggered exposure mode with
a sequenced capture and oriented orthogonal to the laser beam.
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3.3.1.3 Synchronizer
The PIV synchronizer is a programmable timing mechanism that is designed to control
the operation of the complete PIV system. It is the timing master of the system and manages all
timing events needed to make PIV measurements [37]. The PIV measurement process requires
that the different system components, camera, the laser flash lamps and laser Q-switches, are
precisely time coordinated via the execution of programmed time sequences. These sequences
distribute command signals to the camera, laser and other external devices (if applicable). A
choice of automatic and manual configurations is available, covering a large range of
experimental situations from single image acquisition to multi-sequence image bursts, phaselocked operation, internal or external triggering. In this experiment, the synchronizer was
triggered by an external TTL signal that was set to coincide with specific time points in the
generated PIV data. Therefore, images were instantaneously matched with correlating pressure
and flow curve position. In addition, the synchronizer communicates with the other PIV
hardware using TTL signals.
3.3.1.4 Computer
Research utilized a Dell Pentium 4 PC with 512 MB RAM. It contained a 40 GB hard
drive and 1.2 GHz processing speed. The computer communicates with the CCD camera via the
frame grabber which reads the image from the camera and displays it as a digital image on the
monitor. These images are stored in the RAM and processed using the Insight 3.2 PIV software.
Also, the computer is connected to the synchronizer by a RS232 serial cable connection.
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3.3.2 Image Acquisition and Processing
In order to obtain accurate PIV measurements using the aforementioned hardware, TSI
Inc. provided a suggested set of rules in its PIV owner manual [37].

1. The interrogation spot should be small for one vector to describe flow in a single
interrogation spot. This will ensure less averaging, less noise, and good spatial
resolution.

2. There must be more than ten particle image pairs in an interrogation spot. Fewer
particles per interrogation area will decrease the valid detection probability.

3. Maximum in-plane displacement should be less than ¼ of the interrogation spot.
This will minimize loss of particle pairs, making more particle pairs available for
correlation, which increases correlation peak strength.

4. Maximum out of plane displacement should be less than ¼ of laser light sheet
thickness. This will minimize out of plane particle loss.

5. Minimum in-plane displacement should be two particle-image diameters. This
rule ensures that a particle pair is identified as two distinct images of the same
particle as opposed to one elliptical particle image.

6. The exposure must be large enough to clearly show particles.
During the image acquisition process of this experimentation, compliance of the preceding rules
was maintained. This, in addition to other specifics including the frame straddling technique and
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utilization of the Insight software, ensured accurate and repeatable fluid flow representation
through effective image acquisition and vector plot processing.
3.3.2.1 Frame Straddling
The frame transfer period associated with the 30 Hz CCD camera frame rate limits the
minimum time separation between lasers. Hence, high velocity flow analysis is impractical [37].
However this experimentation employs frame straddling to increase the effective frame rate of
the PIV hardware. The frame straddling technique uses a synchronized timing function to pulsate
the laser at the end of the first camera exposure and again at the beginning of the subsequent
exposure. This controlled timing permits the measurement of high velocity fluid flow by
shortening the time interval between laser pulses [37]. The timing diagram for frame straddling
is shown in Figure 3.13.

Figure 3.13. [37] Frame Straddling.

As previously stated, the utilized CCD camera has a fixed rate for frame acquisition but the time
interval between any two images is adjustable, which allows for accurate representation of the
flow field.
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3.3.2.2 Interrogation Area Size
In addition to laser pulse time interval tuning, the size of the interrogation area is another
major determining factor in image acquisition and processing. Interrogation area size was chosen
to minimize noise and increase accuracy. Spatial resolution increases as the interrogation area
size decreases; however, lowering the interrogation area size is more conducive to low velocity
measurements because higher velocities produce more in-plane particle loss [37]. The 1008 x
1018 square pixels CCD camera provides significant precision to the detail seen in a particular
region of interest. The typical size of an interrogation area, as stated by the TSI PIV owner
manual, is 32 x 32 pixels [37]. The Insight software offers the user the ability to mask regions
within the interrogation area so as to ignore user specified regions during post processing. Once
the mask regions are selected the software continues the examination of the remaining unmasked
interrogation areas of the paired frames. During processing of these unmasked areas, each
particle image is identified and matched to the corresponding image of the same particle across a
pair of frames. After identification, their respective locations are computed and compared to one
another using an internal correlation function. The size of the pixel array of the interrogation area
can be modified using the software, which will change the number of velocity vectors to be
calculated.
3.3.2.3 Software
The PIV system utilizes the Insight software to analyze and display velocity vector plots.
The software divides and processes digital images of designated interrogation areas within the
flow field. Insight determines the number of usable particles and their corresponding locations
within the paired frames. These corresponding particle images, within the designated
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interrogation areas, are compared via a correlation function that identifies the most common
displacement in a given time interval and displays it as a velocity vector. Velocity vectors are
shown as graphic overlays across the initial image capture and consist of magnitude and
direction information. The Insight software provides several cross correlation algorithm options
to choose from during analysis including Fast Fourier Transforms (FFT). This experiment
utilizes the HART correlation algorithm that was developed at Massachusetts Institute of
Technology [33]. HART correlation presents the ability to compress data and use intensity
information more efficiently [33]. It produces four times the number of vectors compared to the
frequently used FFT, which enables the system to visualize more detailed fluid flow information
[33].
In order to optimize the image capture process, it is critical to select the proper ∆t value.
The ∆t is the time interval between the independently pulsed laser pulses. ∆t selection can be
done manually or via an internal process conducted by the Insight software that estimates an
optimum ∆t value. In this experiment a ∆t value of 300 µs was used with 25 ms pulse separation.
Additionally, post-processing by the Insight software includes the ability to remove flawed
vectors using a variety of different filters such as mean, median, standard deviation, and
smoothing [33]. Utilization of TecPlot, provides the ability to compute speed, vorticity, velocity
gradients, and flow contours [33].
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4 RESULTS

The ensuing sections present data acquired by the mock loop pressure transducers and
flow meter. This information was displayed, in real-time, on the CPU Dashboard and collected
and stored in an Excel file. A total of twelve different heart rate and stroke volume combinations
were set with corresponding resistances to maintain a peak systolic pressure in the range of 110
to 140 mmHg. This peak systolic pressure was measured by the pressure transducer embedded
within the compliance chamber. The twelve examined combinations are listed in Table 4.1 along
with their corresponding resistor positions. In addition, for each data set a sequence of 20 images
was taken by the PIV system at the MHV test chamber location using a 28mm lens. Only images
from one complete tilting disk valve opening cycle is displayed for each setup. The CCD camera
was operated at a 30 Hz frame rate, which denotes a 33.33 ms time between image captures.
Pressure and flow data are displayed for the time scale ranging from 0 to 3 seconds.
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Heart Rate (BPM) Stroke Volume (mL) Resistor Position
60

70

330

70

70

325

80

70

325

90

70

320

70

50

330

70

60

330

70

80

320

70

90

315

90

55

325

60

60

340

80

80

315

95

80

305

Table 4.1. Experimental heart rate and stroke volume combinations with corresponding resistor position.
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4.1 60 BPM at 70mL Stroke Volume

Figure 4.1a. PIV images of one complete
tilting disk valve opening cycle for 60 BPM
with 70mL SV.
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Figure 4.1b. Pressure (top) and flow (bottom) data for 60 BPM with 70mL SV.

The data in Figure 4.1a and 4.1b was acquired while the Harvard pump was set to
operate at 60 BPM with a 70mL SV. At this HR, the tilting disk valve successfully completes 60
opening cycles per minute. The Harvard pumping cycle is represented by one full phase in each
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of the displayed waves, pressure and flow. The pumping cycle takes 1 second with an average
aortic peak systolic pressure at 116.33 mmHg and average minimum diastolic pressure of 39.00
mmHg. These values were measured by the pressure transducer just before entering the
compliance chamber (99G99F22-X14),

which indicates the natural aortic location.

Measurements inside the compliance chamber indicate a mean mock loop system pressure of
137.33/62.33 mmHg. The tilting disk valve opens 0.1 seconds after the minimum diastolic
pressure occurs and closes 0.15 seconds after peak systolic pressure. The tilting disk valve is
open 0.33 seconds of the pumping cycle. Valve closure is represented by the formulated “dicrotic
notch” on the blue pressure wave above, which marks the end of the systolic period. The dicrotic
notch is signified by the small downward deflection of the blue pressure wave that occurs at t =
0.45, 1.35, and 2.20 seconds. This small fluctuation in the downward slope of the pressure phase
is created by the rebound action of the tilting disk valve, which correlates with the negative flow
values seen at t = 0.45, 1.45, and 2.45 seconds on the flow wave. The flow meter measured an
average high instantaneous flow rate of 11.20 L per minute during the opening of the tilting disk
valve. The cardiac output of the mock loop at these conditions was 4.2 L per minute.
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4.2 70 BPM at 70mL Stroke Volume

Figure 4.2a. PIV images of one complete tilting disk valve opening cycle for
70 BPM with 70mL SV.
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Figure 4.2b. Pressure (top) and flow (bottom) data for 70 BPM with 70mL SV.

Figure 4.2a and 4.2b displays data when the Harvard pump operated at 70 BPM with a
70mL SV. At this HR, the tilting disk valve successfully opens 70 times per minute. The
pumping cycle takes 0.86 seconds with an average aortic peak systolic pressure at 119.33 mmHg
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and average minimum diastolic pressure of 44.00 mmHg measured by pressure transducer
99G99F22-X14. Measurements inside the compliance chamber indicate a mean mock loop
system pressure of 140.00/66.33 mmHg. The tilting disk valve opens 0.09 seconds after the
minimum diastolic pressure occurs and closes 0.13 seconds after peak systolic pressure. The
tilting disk valve is open 0.30 seconds of the pumping cycle. The dicrotic notch occurs at t =
0.43, 1.29, 2.15, and 3.00 and correlates with negative flow values seen at identical times on the
flow wave. The flow meter measured an average high instantaneous flow rate of 13.375 L per
minute during the opening of the tilting disk valve. The cardiac output of the mock loop at these
conditions was 4.9 L per minute.
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4.3 80 BPM at 70mL Stroke Volume

Figure 4.3a. PIV images of one complete tilting disk
valve opening cycle for 80 BPM with 70mL SV.
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Figure 4.3b. Pressure (top) and flow (bottom) data for 80 BPM with 70mL SV.

Figure 4.3a and 4.3b above shows information gathered from the Harvard pump
operated at 80 BPM with a 70mL SV. This HR and SV combination produces a cardiac output of
5.6 L per minute in the mock loop. The pumping cycle has an average aortic peak systolic
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pressure at 119.33 mmHg, average minimum diastolic pressure of 44.00 mmHg, and a total
duration of 0.75 seconds with these pressure values measured by pressure transducer 99G99F22X14. The tilting disk valve opens 80 times per minute. The pressure transducer inside the
compliance chamber monitors a mean mock loop system pressure of 135.67/65.00 mmHg. The
tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 0.12
seconds after peak systolic pressure. The tilting disk valve is open 0.23 seconds of the pumping
cycle. The dicrotic notch occurs at t = 0.35, 1.10, 1.85, and 2.60 seconds and correlates with
negative flow values seen at identical times on the flow wave. The flow meter measured an
average high instantaneous flow rate of 15.90 L per minute during the opening of the tilting disk
valve.
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4.4 90 BPM at 70mL Stroke Volume

Figure 4.4a. PIV images of one complete tilting disk
valve opening cycle for 90 BPM with 70mL SV.
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Figure 4.4a. Pressure data (top) and flow (bottom) data for 90 BPM with 70mL SV.

Data illustrated in Figure 4.4a and 4.4b is representative of a 90 BPM, 70mL SV
Harvard pump operation. The tilting disk valve completes 90 opening cycles per minute during a
0.67 second pumping cycle interval. The average aortic peak systolic pressure and average
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minimum diastolic pressure were 102.00 mmHg and 41.50 mmHg, respectively, measured by the
99G99F22-X14 pressure transducer. Measurements inside the compliance chamber indicate a
mean mock loop system pressure of 120.40/52.00 mmHg. The dicrotic notch occurs at the
instance of negative flow on the flow wave at t = 0.33, 1.00, 1.67, 2.34, and 3.00. The opening of
the tilting disk valve produces a mock loop average high instantaneous flow rate of 17.02 L per
minute. The tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and
closes 0.12 seconds after peak systolic pressure. One tilting disk opening sequence inhabits 0.22
seconds of the total pumping cycle time. The cardiac output of the mock loop at these conditions
was 6.3 L per minute.
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4.5 70 BPM at 50mL Stroke Volume

Figure 4.5a. PIV images of one complete tilting disk valve opening cycle for 70
BPM with 50mL SV.
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Figure 4.5b. Pressure (top) data and flow (bottom) data for 70 BPM with 50mL SV.

Figure 4.5a and 4.5b above shows information gathered from the Harvard pump
operated at 70 BPM with a 50mL SV. This HR and SV combination produces a cardiac output of
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3.5 L per minute in the mock loop. The pumping cycle has an average aortic peak systolic
pressure at 96.25 mmHg, average minimum diastolic pressure of 29.67 mmHg, and a total
duration of 0.86 seconds with these pressure values measured by pressure transducer 99G99F22X14. The tilting disk valve cycles 70 times per minute. The pressure transducer inside the
compliance chamber monitors a mean mock loop system pressure of 117.50/61.00 mmHg. The
tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 0.13
seconds after peak systolic pressure. The tilting disk valve is open 0.30 seconds of the pumping
cycle. The dicrotic notch occurs at t = 0.41, 1.27, 2.13, and 2.99 seconds and correlates with
negative flow values seen at identical times on the flow wave. The flow meter measured an
average high instantaneous flow rate of 9.625 L per minute during the opening of the tilting disk
valve.
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4.6 70 BPM at 60mL Stroke Volume

Figure 4.6a. PIV images of one complete tilting disk valve opening cycle for 70 BPM
with 60mL SV.
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Figure 4.6b. Pressure (top) data and flow (bottom) data for 70 BPM with 60mL SV.

Figure 4.6a and 4.6b displays data when the Harvard pump operated at 70 BPM with a
60mL SV. At this HR, the tilting disk valve successfully opens 70 times per minute. The
pumping cycle takes 0.86 seconds with an average aortic peak systolic pressure at 116.50 mmHg
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and average minimum diastolic pressure of 47.67 mmHg measured by pressure transducer
99G99F22-X14. Measurements inside the compliance chamber indicate a mean mock loop
system pressure of 139.25/76.00 mmHg. The tilting disk valve opens 0.09 seconds after the
minimum diastolic pressure occurs and closes 0.13 seconds after peak systolic pressure. The
tilting disk valve is open 0.30 seconds of the pumping cycle. The dicrotic notch occurs at t =
0.43, 1.29, 2.15, and 3.00 and correlates with negative flow values seen at identical times on the
flow wave. The flow meter measured an average high instantaneous flow rate of 11.275 L per
minute during the opening of the tilting disk valve. The cardiac output of the mock loop at these
conditions was 4.2 L per minute.
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4.7 70 BPM at 80mL Stroke Volume

Figure 4.7a. PIV images of one complete tilting disk valve opening cycle for 70 BPM
with 80mL SV.
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Figure 4.7b. Pressure (top) data and flow (bottom) data for 70 BPM with 80mL SV.

Graphs in Figure 4.7a and 4.7b are representative of a 70 BPM, 80mL SV Harvard pump
operation. The tilting disk valve completes 70 opening cycles per minute during a 0.86 second
pumping cycle interval. It opens 0.1 seconds after the minimum diastolic pressure occurs and
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closes 0.13 seconds after peak systolic pressure. One tilting disk opening sequence inhabits 0.30
seconds of the total pumping cycle time. The average aortic peak systolic pressure and average
minimum diastolic pressure were 103.00 mmHg and 30.00 mmHg, respectively, measured by the
99G99F22-X14 pressure transducer. Measurements inside the compliance chamber indicate a
mean mock loop system pressure of 124.00/49.33 mmHg. The dicrotic notch occurs at the
instance of negative flow on the flow wave at t = 0.25, 1.11, 1.91, and 2.77. The opening of the
tilting disk valve produces a mock loop average high instantaneous flow rate of 17.00 L per
minute. The cardiac output of the mock loop at these conditions was 5.6 L per minute.
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4.8 70 BPM at 90mL Stroke Volume

Figure 4.8a. PIV images of one complete tilting disk valve opening cycle for 70 BPM
with 90mL SV.
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Figure 4.8b. Pressure data (top) and flow (bottom) data for 70 BPM with 90mL SV.

Figure 4.8a and 4.8b above shows information gathered from the Harvard pump
operated at 70 BPM with a 90mL SV. It creates a cardiac output of 6.3 L per minute in the mock
loop. The pumping cycle has an average aortic peak systolic pressure at 93.50 mmHg, average

83

minimum diastolic pressure of 18.00 mmHg, and a total duration of 0.86 seconds with these
pressure values measured by pressure transducer 99G99F22-X14. The pressure transducer inside
the compliance chamber monitors a mean mock loop system pressure of 117.50/35.33 mmHg.
The tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes
0.12 seconds after peak systolic pressure. It opens 70 times per minute during a 0.30 second
pumping cycle. The dicrotic notch occurs at t = 0.40, 1.26, 2.12, and 2.98 seconds and correlates
with negative flow values seen at identical times on the flow wave. The flow meter measured an
average high instantaneous flow rate of 18.45 L per minute, which denotes the opening of the
tilting disk valve.

84

4.9 90 BPM at 55mL Stroke Volume

Figure 4.9a. PIV images of one complete tilting disk valve opening cycle for 90 BPM
with 55mL SV.
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Figure 4.9b. Pressure (top) data and flow (bottom) data for 90 BPM with 55mL SV.

A cardiac output of 4.95 L per minute was created in the mock loop by running the
Harvard pump at 90 BPM with a 55mL SV. Figure 4.9a and 4.9b above shows the acquired
data. The average aortic peak systolic pressure of the pumping cycle is 98.60 mmHg and average
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minimum diastolic pressure was 38.25 mmHg measured by pressure transducer 99G99F22-X14
at the mock loop aortic location. One pumping cycle lasted 0.67 seconds and contains one valve
opening phase; the tilting disk valve opens 90 times per minute under these conditions. The valve
opens for 0.22 seconds during the pumping cycle where initiation occurs 0.1 seconds after the
minimum diastolic pressure and closure 0.13 seconds after peak systolic pressure. The pressure
transducer inside the compliance chamber registers a mean mock loop system pressure of
118.40/62.25 mmHg. The dicrotic notch and negative flow regions occur at t = 0.31, 0.98, 1.65,
2.32, and 2.99 seconds. The flow meter measured an average high instantaneous flow rate of
15.55 L per minute during the opening of the tilting disk valve.
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4.10 60 BPM at 60mL Stroke Volume

Figure 4.10a. PIV images of one complete
tilting disk valve opening cycle for 60 BPM
with 60mL SV.
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Figure 4.10b. Pressure (top) and flow (bottom) data for 60 BPM with 60mL SV.
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The data in Figure 4.10a and 4.10b was acquired while the Harvard pump was set to
operate at 60 BPM with a 60mL SV. At this HR, the tilting disk valve completed 60 opening
cycles per minute. The Harvard pumping cycle takes 1 second with an average aortic peak
systolic pressure at 116.00 mmHg and average minimum diastolic pressure of 40.00 mmHg
measured by the pressure transducer just before entering the compliance chamber (99G99F22X14). Measurements inside the compliance chamber indicate a mean mock loop system pressure
of 132.00/66.67 mmHg. The tilting disk valve opens 0.1 seconds after the minimum diastolic
pressure occurs and closes 0.14 seconds after peak systolic pressure. The tilting disk valve is
open 0.33 seconds of the pumping cycle. Small downward deflection of the blue pressure wave
(dicrotic notch) at t = 0.45, 1.45, and 2.45 correlate with the negative flow values on the flow
wave. The flow meter measured an average high instantaneous flow rate of 9.47 L per minute
during the opening of the tilting disk valve. The cardiac output of the mock loop at these
conditions was 3.6 L per minute.
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4.11 80 BPM at 80mL Stroke Volume

Figure 4.11a. PIV images of one complete tilting
disk valve opening cycle for 80 BPM with 80mL SV.
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Figure 4.11b. Pressure (top) and flow (bottom) data for 80 BPM with 80mL SV.

Figure 4.11a and 4.11b above shows information gathered from the Harvard pump
operated at 80 BPM with a 80mL SV. This HR and SV combination produces a cardiac output of
6.4 L per minute in the mock loop. The pumping cycle has an average aortic peak systolic
pressure at 101.50 mmHg, average minimum diastolic pressure of 33.25 mmHg, and a total
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duration of 0.75 seconds with these pressure values measured by pressure transducer 99G99F22X14. The tilting disk valve opens 80 times per minute. The pressure transducer inside the
compliance chamber monitors a mean mock loop system pressure of 120.00/44.25 mmHg. The
tilting disk valve opens 0.1 seconds after the minimum diastolic pressure occurs and closes 0.12
seconds after peak systolic pressure. The tilting disk valve is open 0.23 seconds of the pumping
cycle. The dicrotic notch occurs at t = 0.30, 1.05, 1.82, and 2.60 seconds and correlates with
negative flow values seen at identical times on the flow wave. The flow meter measured an
average high instantaneous flow rate of 17.675 L per minute during the opening of the tilting
disk valve.
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4.12 95 BPM at 80mL Stroke Volume

Figure 4.12a. PIV images of one complete tilting
disk valve opening cycle for 95 BPM with 80mL
SV.
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Figure 4.12b. Pressure (top) and flow (bottom) data for 95 BPM with 80mL SV.

Illustrations in Figure 4.12a and 4.12b present data for a 95 BPM, 80mL SV Harvard
pump operation. The tilting disk valve completes 95 opening cycles per minute during a 0.63
second pumping cycle interval. The average aortic peak systolic pressure and average minimum
diastolic pressure were 99.80 mmHg and 32.25 mmHg, respectively, measured by the
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99G99F22-X14 pressure transducer. Measurements inside the compliance chamber indicate a
mean mock loop system pressure of 118.20/38.00 mmHg. The dicrotic notch occurs at the
instance of negative flow on the flow wave at t = 0.38, 1.01, 1.72, and 2.35. The opening of the
tilting disk valve produces a mock loop average high instantaneous flow rate of 22.14 L per
minute. The tilting disk valve opens 0.12 seconds after the minimum diastolic pressure occurs
and closes 0.15 seconds after peak systolic pressure. One tilting disk opening sequence inhabits
0.21 seconds of the total pumping cycle time. The cardiac output of the mock loop at these
conditions was 7.6 L per minute.
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4.13 Vector Plots
In order to provide evidence of the ability to obtain vector plot data using this system,
one set of PIV images were post-processed. Figure 4.13a through 4.13i show vector information
downstream of the experimental tilting disk valve at 60 BPM with 60mL SV. Unlike the
previous results, these images were captured orthogonal to the fluid flow region using a 50 mm
lens, which provides a more localized imaging area. In these vector plots, positive fluid flow is
indicated by right pointing arrows and the tilting disk valve is located to the left of the vector
plot.

Figure 4.13a. Vector plot for 60 BPM with 60mL SV. End of systolic phase, just before valve closure.
Entering pump drawback.
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Figure 4.13a represents flow at the end of the pump systolic phase and just before the valve
closes. The majority of the shown vectors are oriented in the reverse direction. This indicates that
the pump is entering drawback and there is negative fluid flow. Several regions present a
swirling, turbulent flow area within the flow as the fluid flow transfers from predominantly
positive, forward movement to negative, backflow.

Figure 4.13b. Vector plot for 60 BPM with 60mL SV. Beginning of diastolic phase, just after valve
closure, start of pump drawback.

Figure 4.13b represents flow at the beginning of the pump diastolic phase and just after the
valve closure. Most vectors are oriented in the reverse direction except those involved in areas of
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turbulence. Pump drawback continues to induce negative fluid flow. Once again, several regions
present a swirling, turbulent flow area within the flow; however, those regions are limited when
compared to Figure 4.13a.

Figure 4.13c. Vector plot for 60 BPM with 60mL SV. Diastolic phase, valve closed, middle of pump
drawback.

Figure 4.13c displays fluid flow during the pump diastolic phase. The test tilting disk valve has
completely closed at this point. Pump drawback continues to induce negative fluid flow, which
gives the vector an overall reverse current orientation. It shows a large stagnant region just
downstream of the MHV location.
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Figure 4.13d. Vector plot for 60 BPM with 60mL SV. Diastolic phase, valve closed, pump still in
drawback.

Figure 4.13d looks very similar to Figure 4.13c. In this figure fluid flow is presented during the
pump diastolic phase. The test tilting disk valve is still completely closed and pump drawback
causes negative fluid flow, as evidenced by the negative vector plot directions. The large
stagnant region remains just downstream of the MHV location.
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Figure 4.13e. Vector plot for 60 BPM with 60mL SV. Diastolic phase, valve closed, end pump drawback.

Figure 4.13e displays fluid flow during the pump diastolic phase and at the end of pump
drawback. The test tilting disk valve is completely closed and reverse fluid current is still
evident. A stagnant flow region to the far left of the vector plot area is present.
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Figure 4.13f. Vector plot for 60 BPM with 60mL SV. End of diastolic phase, just prior to valve opening.

Figure 4.13f displays fluid flow at the end of the pump diastolic phase, just prior to opening of
the tilting disk valve. The pump piston has begun its forward progression as it forces fluid out of
the pump chamber; however, the effects have yet to show up in the vector plot. It still displays
predominantly negative flow orientation but the stagnant flow region just downstream of the
MHV location has reduced when compared to the previous figures.
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Figure 4.13g. Vector plot for 60 BPM with 60mL SV. Start of systolic phase, just after valve opening.

Figure 4.13g displays fluid flow at the start of the pump systolic phase. The test tilting disk
valve has just opened and the vector plot reflects the positive fluid flow caused by the rush of
fluid through the valve. It shows a large stagnant region just downstream of the MHV location.
Several regions present a swirling, turbulent flow area as the fluid flow transfers from
predominantly negative, backflow to positive, forward movement.
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Figure 4.13h. Vector plot for 60 BPM with 60mL SV. Systolic phase, valve open.

Figure 4.13h displays fluid flow during the pump systolic phase. The test tilting disk valve is
open. The vector plot shows several swirling, turbulent flow regions as fluid velocity increases
through the MHV. The longer vectors indicate larger absolute velocity measurements.
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Figure 4.13i. Vector plot for 60 BPM with 60mL SV. Peak systolic phase, valve completely open.

Figure 4.13i presents fluid flow at peak pump systole when the test tilting disk valve is
completely open. The vector plot continues to display several swirling, turbulent flow regions as
fluid velocity is at its maximum.
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5 DISCUSSION, CONCLUSION, AND LIMITATIONS

5.1 Discussion
This experiment included 12 different conditional setups with 20 images captured for
each at the MHV test chamber location in the automated mock circulatory loop in the Artificial
Heart Laboratory at Virginia Commonwealth University. The images are captured in sequence,
33.33 ms apart, and depicted the operation of an experimental tilting disk valve for the following
combinations of HR-SV parameters: 1. 60BPM-70mL, 2. 70BPM-70mL, 3. 80BPM-70mL, 4.
90BPM-70mL, 5. 70BPM-50mL, 6. 70BPM-60mL, 7. 70BPM-80mL, 8. 70BPM-90mL, 9.
90BPM-55mL, 10. 60BPM-60mL, 11. 80BPM-80mL, and 12. 95BPM-80mL. One tilting disk
valve opening cycle was presented for each experimental condition set. The systolic to diastolic
phase ratio was 50% for all setups and the mock loop peripheral resistor was altered for each in
order to maintain a peak systolic pressure in the mock loop compliance chamber within the range
of 110 to 140 mmHg. This experiment helps to determine the effectiveness of a completely
automated mock circulatory loop and a novel test chamber in the evaluation of MHVs. It
primarily focuses on the ability to gather relative fluid dynamic data, at the MHV location, while
providing the capability to quickly interchange MHV types and set various physiological
conditions. Thus, the objective was to improve upon the efficiency of current MHV in vitro test
methods by developing a system that requires less time to manipulate loop parameters and
components while maintaining current MHV testing loop and chamber standards.
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5.1.1 Mock Circulatory Loop Performance
Evaluation of the experimental mock circulatory loop system for MHV performance
testing consisted of satisfaction of two primary criterion: 1. the system’s capacity to produce
pressure waves similar to those shown in a typical Wiggers diagram, and 2. the system’s ability
to expose the test MHV at a wide range of mimicked physiological conditions.
5.1.1.1 Wiggers Diagram Comparison
The observed shapes of the collected mock loop pressure waveforms effectively compare
to the theoretical cardiac Wiggers diagram. As shown in Figure 5.1, the three major regions of
the aortic pressure response, denoted by the theoretical Wiggers diagram, were successfully
exhibited by the experimental mock loop system. The labeled regions designate the following
occurrences within the native heart cycle.
a. represents the opening of the aortic valve and the beginning of left ventricular systole
b. represents the peak systolic pressure
c. represents the closing of the aortic valve and the end of left ventricular systole
Furthermore, Figure 5.2 shows the left ventricular pressure response, which also indicates a high
correlation between the Wiggers diagram and the experimental mock loop pressure waveform.
Presence of the labeled regions in Figure 5.2 indicates the following.
d. represents closure of the mitral valve and the end of left ventricular diastole
e. represents the opening of the mitral valve and the beginning of left ventricular
diastole
The generation of the aforementioned regions by the experimental mock loop confirms its ability
to adequately duplicate the events of the native left ventricle heart cycle.
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Figure 5.1. Aortic pressure waveform shape comparison to theoretical Wiggers diagram.

Figure 5.2. Left ventricular pressure waveform shape comparison to theoretical Wiggers diagram.
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Figure 5.3 illustrates the typical pressure range (mmHg) presented by the Wiggers
diagram as compared to the pressure range (mmHg) created by the experimental mock loop at 60
BPM and 60 mL SV. The Wiggers diagram has an effective left ventricular pressure range of
120 mmHg and an effective aortic pressure range of 40 mmHg. In addition, both Wiggers
diagram pressure waveforms peak at approximately 120 mmHg. For the experimental mock
loop, the effective left ventricular pressure range is approximately 65 mmHg and the effective
aortic pressure range is approximately 50 mmHg. In addition, the difference between the peak
systolic pressure of the aortic pressure replication and the left ventricular pressure representation
is approximately 15 mmHg. This loss of energy can be attributed to the drawback nature of the
pump which lowers the pressure values considerably. Since the test MHV is located closer to the
pump than the compliance chamber, the pumps negative pressure has a much greater effect on
the aortic pressure replication data than on the left ventricular pressure representation data. In
sense, the MHV shields the compliance chamber pressure from being dragged down as the
pulsatile pump enters diastole. This pump drawback is explained in more detail in the
“Experimental Errors and Limitations” section.
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Figure 5.3. Pressure waveform range comparison to theoretical Wiggers diagram.

5.1.1.2 Physiological Simulation Range
The experimental mock loop was able to effectively mimic a wide range of physiological
pathologies via manipulation of fluid dynamics. The Harvard pulsatile pump was able to produce
a number of HR-SV combinations with HR ranging from 0 to 95 BPM and SV ranging from 15
to 100 mL. Increasing or decreasing one or both HR or SV alters the system cardiac output
which simulates conditions including rest, normal, exercise, and failing heart scenarios. This
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allows for the observation of MHV performance through the measurement of fluid dynamic
information such as pressure and flow rate. Validation of HR and SV settings was completed via
analysis of pressure and flow data waveforms. HR was checked for accuracy by pressure and
flow wave frequency calculation and SV was confirmed by integration under the flow wave. The
scope of the Harvard pump in conjunction with capacitance and resistance manipulation
presented the ability to effectively imitate the native’s heart capacity to operate in various
pathologies. Furthermore, the transformation from manual control to digital control of these
components, with feedback assessment, allowed for relatively instantaneous interchangeability
between the mimicked physiological conditions.

5.1.2 Pressure and Flow Data
Pressure measurements throughout experimentation provided feedback for the monitoring
of aortic pressure just after the tilting disk valve in the mock loop. Each of the acquired pressure
waveforms effectively mimic the aortic pressure waveforms created by the native heart. These
waveforms include a rapid increase in pressure up to the peak systolic pressure and a slower
decline to minimum diastolic pressure. Observation of the aortic pressure waveform also shows
the opening of the tilting disk valve during the rapid increase phase and closure during the slow
decline phase. Both the opening and closure are denoted by sudden pressure value fluctuations in
the relatively smooth wave. At the onset of valve opening, aortic pressure drops suddenly due to
the increase in volume area because the valve no longer provides resistance to the fluid. This
pressure drop is fairly small in time because the abrupt rush of fluid into the aorta causes the
aortic pressure to once again rise until it reaches the peak systolic pressure. Similarly, a sudden
rise in pressure occurs during the slow fall of aortic pressure as the valve closes. This pressure
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fluctuation is more commonly known as the dicrotic notch. The dicrotic notch occurs when the
valve closes and restricts fluid flow, thus, momentarily trapping a high volume of fluid in the
aorta. Almost instantaneously the aorta constricts and forces the fluid through the circulatory
system, which once again causes the aortic pressure to fall. These changes form a small
“sawtooth” indentation in the pressure waveform. Location of the dicrotic notch is a major
notification in the diagnosis of several pathologies such as hypovolemia. Therefore, the dicrotic
notch is a good indication of valve functionality and its consequent effects on fluid flow. Valve
closure is also indicative of flow stagnation, which is linked to thrombotic activity. Furthermore,
manipulation of the peak systolic pressure by capacitance and resistance variability presents the
ability to expose test MHVs to different mechanical conditions, which is important during
durability and mechanical failure testing. The system also created a fairly low diastolic pressure
for all condition experiments, which will be further discussed in the errors and limitations
section.
In addition to pressure data, flow data is extremely important in MHV performance
evaluation. The instantaneous detection of fluid flow just after the valve provides information for
the effects of valve design on fluid dynamics. Negative flow regions on the flow waveform
suggests periods of backflow during circulation, especially at the test MHV location. Backflow
plays a role in valve closure and is a means of washing thrombus deposition from the valve. It is
created when filling of the pump during the diastolic phase presents a low pressure in the pump
while the pressure in the aortic section remains high. This pressure gradient forces flow to move
from the region of high pressure towards the region of low pressure in order to stabilize the
system. Low aortic pressures present little to no backflow; however, high aortic pressures cause
the magnitude of fluid backflow to rise. Thus, in the instance of a faulty valve and high aortic
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pressure, backflow will negatively affect cardiac output. Additionally, backflow also leads to
flow recirculation or swirling. So if MHV design creates a high shear stress region and the blood
flows back through that region during backflow it raises the exposure time of the red blood cells
to high shear stress which raises the potential for hemolytic activity. MHVs that present high
potentials for thrombosis and/or hemolysis are not ideal for implantation, which enhances the
significance of in vitro testing and measurement of fluid flow. Therefore, the instantaneous flow
measurement and ability to quickly change physiological conditions become increasingly more
important.

5.1.3 PIV Imaging
For the purpose of this research, images acquired by the PIV system were used to validate
proper valve mechanical functionality and particle illumination for post-processing. Particle
illumination is a key element in computing fluid flow profiles. These profiles, usually vector
and/or contour plots, provide local velocity information for a designated flow field. Therefore,
they relay qualitative and quantitative visualization data relevant to stagnant and swirling
backflow regions that may promote thrombotic and/or hemolytic activity. In this
experimentation, imaging at the test valve site in the mock loop showed adequate particle
illumination and thus, with further processing, will provide local velocity data of fluid flow
exiting the valve. This will allow in vitro prediction of native fluid dynamics for a particular
valve design. In order to establish proof of concept for this imaging data, vector plot postprocessing was completed for only one parameter set, 60 BPM at 60mL SV.
Furthermore, synchronization of the image acquisition process with the mock loop
measuring instruments enabled flow field interpretations to be developed from the computed
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pressure and flow waveforms. This was completed via the implementation of a time-stamp,
generated TTL signal that initiated the PIV imaging process. As previously noted, negative
measurements on the flow waveform indicate reversal of fluid flow, backflow. These negative
flow time periods begin just before the valve closes, as the last couple of images in each set of
tilting disk valve opening cycle illustrations. Furthermore, negative flow recordings coincide
with the Harvard pump’s diastolic phase in which its function is dominated by the motor
drawback mechanics. Pump diastole ensues throughout valve closure. The combination of these
phenomena implies regurgitant or swirling flow at the tilting disk valve location during its
closing phase. Integration of the negative flow region provided quantitative data with respect to
the amount of backflow observed during each set of operating conditions. From this data, it was
observed that regurgitant volume increased with SV increase and decreased with HR escalation.
These regurgitant volume responses can be attributed to direct relationships to total volume
discharged by the pump, SV, and total time spent in diastolic phase, HR. Total backflow volume
is proportional to SV, so a change in one represents a similar change in the other, when all other
loop parameters are held constant. In contrast, total backflow volume is indirectly related to the
amount of time that the valve is exposed to the diastolic phase of the pump. Therefore, as HR
increases, the pump diastolic phase duration is lowered and less backflow occurs. The highest
amount of backflow was seen at 60 BPM and 70mL SV, while the least was at 90 BPM and
55mL SV. Indicating that HR had a greater effect on regurgitant volume than SV in the
investigated mock loop system. Lastly, all acquired images showed the tilting disk valve opening
to a 60 degree tilt that produced a major and minor flow region.
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5.2 Experimental Errors and Limitations
A consistent, uniform experimental setup is always ideal in research. However,
procedural errors and/or limitations will continually present the opportunity for deviation away
from the ideal scenario. During this experimentation, most faults were attributed to the Harvard
pulsatile pump with the biggest setback occurring in the diastolic phase of the pumping cycle.
Unlike the natural positive pressure filling ventricle, the Harvard pulsatile pump in this research
creates a negative pressure head, up to -90 mmHg, during its filling phase. This large negative
pressure creates a larger transvalvular pressure gradient across the test valve, when compared to
observed native behavior, because it pulls down the pressure in the section of the mock just
before the valve. The enhanced pressure differential on each side of the valve causes an
increased backflow response as the fluid rapidly attempts to move from the high pressure aortic
region back through the valve, in the reverse direction, towards the lower pressure area on the
other side. So as the valve prepares to close, a larger than normal amount of fluid regurgitates
back through the valve prior to shutting. The pump’s negative pressure phenomenon drags the
diastolic pressure in the system down to a lower than expected value and also slightly raises the
systolic pressure. It also lowers the anticipated cardiac output value. For example, running the
pump at 60 BPM with a 60mL SV produces a regurgitant value of approximately 25mL per
stroke, which creates a cardiac output of 2.1 L/min. This is a 1.5 L/min reduction from the
expected 3.6 L/min cardiac output, which is about a 40% deviation. This creates major errors
when attempting to evaluate valve performance during the diastolic phase and in relation to the
amount of reverse flow generated by a particular valve design.
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In addition to the error created by the problem above, another limitation is seen in the
Harvard pump’s systolic to diastolic phase ratio. At the time of this experimentation, the pump
was only able to operate in a 50% systolic to diastolic phase ratio setting because digital control
had yet to be resolved for this aspect of pump functionality. The manual version of the Harvard
pump was able to pulse with systolic/diastolic phase ratios ranging from 35 to 50%. Therefore,
upon resolution of pump phase automation the pump will have similar limits. Native normal
systolic/diastolic phase ratio is around 35 to 40%, which produces a slower pressure decent
during the diastolic phase on a native normal ventricular pressure waveform, duplicated by the
mock loop compliance chamber. In this experimentation, analysis of the pressure waveform
within the compliance chamber shows a symmetrical wave phase. This is attributed to the equal
amount of time spent in the systolic and diastolic phases during one pumping cycle. Therefore,
the Harvard pulsatile pump will be able to provide a broader range of physiological pathologies
when the initial manual systolic/diastolic phase ratio range is reestablished.

5.3 Possible Future Progression
The research location, Artificial Heart Laboratory at Virginia Commonwealth University,
is in the process of making numerous other advancements in mock loop in vitro evaluation
including improvements in aortic anatomical relevancy and adaptation of a second loop capacitor
to simulate ventricular compliance. These improvements will further push the envelope of MHV
in vitro independent and comparative testing by providing an advanced duplication of the native
cardiovascular system. This assumption is based upon the notion that the ideal in vitro mock loop
setup will perfectly simulate native physiology and provide the most reliable data.
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5.4 Conclusion
With CHD being the leading cause of death in the United States and the number of global
surgical heart valve procedures expected to exceed 850,000 annually by the year 2050 [4], heart
valve treatment continues to major effects on the world’s population. In particular, patients who
suffer from severe heart valve disorder and require replacement are in need of the development
of an ideal valve replacement that provides longevity and minimal complications after
implantation. MHVs are known to excel in durability concerns; however, questions of
biocompatibility continue to warrant investigation into design improvements. The research
presented here details the formulation of an in vitro process used to evaluate MHV functionality
prior to patient implantation based upon fluid flow dynamics. The experimentation involves the
design and manufacturing of a novel MHV test chamber in conjunction with an automated mock
circulatory loop to improve upon the efficiency of other previous test setups. Emphasis was
placed on the ability to reproduce a wide range of physiological pathologies as well as
effectively image fluid flow and valve operation at the MHV test chamber location. Results
presented positive feedback in reference to the mock loop’s ability to mimic the native
cardiovascular system and the PIV system’s capacity to illuminate particles at the exit region of
the test tilting disk heart valve, placed in the aortic valve position. A total of 12 HR-SV
combinations were examined with all producing acceptable pressure and flow waveforms and
image capture. Transformation from one set of parameters to another was relatively
instantaneous and required minimal movement from the control computer site. Furthermore,
proof of vector plot computation was presented. For these reasons, the researched novel MHV
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test chamber, in conjunction with an automated mock loop, effectively functions as a test
apparatus for MHV evaluation while improving upon the time and accuracy associated with
alternate methods and systems. To increase accuracy in diastolic phase studies, the effects of the
Harvard pump’s production of negative pressure during the diastolic phase should be further
investigated and improved upon.
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